Gene Symbol | Gene ID | Gene Info |
---|---|---|
Spic
|
ENSMUSG00000004359.10 | Spi-C transcription factor (Spi-1/PU.1 related) |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Spic | mm10_chr10_89257304_89257504 | -0.82 | 1.1e-14 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_84181102_84182153 | 30.52 |
Gm36279 |
predicted gene, 36279 |
4129 |
0.18 |
chr5_148379511_148379873 | 25.98 |
Slc7a1 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
8146 |
0.24 |
chr9_113941501_113941655 | 23.65 |
Ubp1 |
upstream binding protein 1 |
9924 |
0.2 |
chr6_124919273_124920636 | 21.10 |
Ptms |
parathymosin |
149 |
0.88 |
chr19_55284094_55284395 | 20.65 |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
90 |
0.97 |
chr18_56977792_56978080 | 20.34 |
C330018D20Rik |
RIKEN cDNA C330018D20 gene |
2568 |
0.32 |
chr10_99268740_99269700 | 19.90 |
Gm34921 |
predicted gene, 34921 |
1226 |
0.27 |
chr4_80311177_80311359 | 19.76 |
Gm11406 |
predicted gene 11406 |
129130 |
0.06 |
chr6_113691177_113691368 | 19.11 |
Irak2 |
interleukin-1 receptor-associated kinase 2 |
527 |
0.5 |
chr18_25097355_25097753 | 18.54 |
Fhod3 |
formin homology 2 domain containing 3 |
26807 |
0.22 |
chr6_88915651_88916398 | 18.19 |
Gm44178 |
predicted gene, 44178 |
3684 |
0.14 |
chr1_167369953_167370207 | 17.92 |
Aldh9a1 |
aldehyde dehydrogenase 9, subfamily A1 |
5914 |
0.14 |
chr4_140701770_140702866 | 17.70 |
Rcc2 |
regulator of chromosome condensation 2 |
845 |
0.47 |
chr19_32180169_32180459 | 17.57 |
Sgms1 |
sphingomyelin synthase 1 |
16114 |
0.21 |
chr17_48300203_48300827 | 16.87 |
Treml2 |
triggering receptor expressed on myeloid cells-like 2 |
129 |
0.94 |
chr11_115717711_115718019 | 16.62 |
Gm11703 |
predicted gene 11703 |
6943 |
0.1 |
chr13_107101149_107101349 | 16.36 |
Gm31452 |
predicted gene, 31452 |
37554 |
0.14 |
chr11_62148607_62148762 | 16.28 |
AL592080.1 |
sperm antigen with calponin homology and coiled-coil domains 1 (Specc1) pseudogene |
31265 |
0.16 |
chr10_128218579_128218730 | 15.93 |
Spryd4 |
SPRY domain containing 4 |
6847 |
0.08 |
chr7_143005357_143005799 | 15.74 |
Tspan32 |
tetraspanin 32 |
60 |
0.96 |
chr3_100436826_100437140 | 15.60 |
Gm43121 |
predicted gene 43121 |
851 |
0.54 |
chr14_31260375_31260754 | 15.19 |
Bap1 |
Brca1 associated protein 1 |
3073 |
0.14 |
chr10_54039973_54040637 | 15.18 |
Gm47917 |
predicted gene, 47917 |
23506 |
0.18 |
chr13_52572586_52572737 | 15.13 |
Syk |
spleen tyrosine kinase |
10512 |
0.26 |
chr15_57892271_57893000 | 15.08 |
Derl1 |
Der1-like domain family, member 1 |
187 |
0.95 |
chr6_57767219_57767399 | 14.90 |
Vopp1 |
vesicular, overexpressed in cancer, prosurvival protein 1 |
57331 |
0.07 |
chr5_36563157_36563456 | 14.81 |
Tbc1d14 |
TBC1 domain family, member 14 |
750 |
0.62 |
chr6_31613580_31613892 | 14.64 |
Gm43154 |
predicted gene 43154 |
8447 |
0.19 |
chr19_4059281_4059805 | 14.49 |
Gstp3 |
glutathione S-transferase pi 3 |
26 |
0.92 |
chr2_174614009_174614190 | 14.37 |
Vmn1r-ps1 |
vomeronasal 1 receptor, pseudogene 1 |
22869 |
0.17 |
chr8_88300266_88300451 | 14.34 |
Adcy7 |
adenylate cyclase 7 |
21 |
0.98 |
chr15_16566243_16566682 | 14.34 |
Gm2611 |
predicted gene 2611 |
34100 |
0.19 |
chr11_19924323_19926342 | 14.29 |
Spred2 |
sprouty-related EVH1 domain containing 2 |
890 |
0.71 |
chr5_67280465_67280714 | 14.22 |
Gm42670 |
predicted gene 42670 |
19327 |
0.15 |
chr2_168206505_168207218 | 14.21 |
Adnp |
activity-dependent neuroprotective protein |
61 |
0.95 |
chr7_19266027_19266190 | 14.06 |
Vasp |
vasodilator-stimulated phosphoprotein |
438 |
0.62 |
chr10_51453996_51454265 | 13.90 |
Gm46189 |
predicted gene, 46189 |
1850 |
0.26 |
chr5_139380266_139381195 | 13.86 |
Gpr146 |
G protein-coupled receptor 146 |
149 |
0.92 |
chr8_117201413_117201601 | 13.56 |
Gan |
giant axonal neuropathy |
43370 |
0.14 |
chr8_122547810_122548264 | 13.56 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
3292 |
0.12 |
chr13_45512556_45512768 | 13.39 |
Gmpr |
guanosine monophosphate reductase |
1178 |
0.54 |
chrX_142385076_142385241 | 13.35 |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
5186 |
0.17 |
chr9_114742924_114743099 | 13.24 |
Cmtm6 |
CKLF-like MARVEL transmembrane domain containing 6 |
11838 |
0.16 |
chr9_32400635_32401003 | 13.21 |
Kcnj1 |
potassium inwardly-rectifying channel, subfamily J, member 1 |
6834 |
0.18 |
chr7_122132401_122133528 | 13.11 |
Palb2 |
partner and localizer of BRCA2 |
18 |
0.54 |
chr12_24890162_24890450 | 12.98 |
Mboat2 |
membrane bound O-acyltransferase domain containing 2 |
58675 |
0.09 |
chr18_74294664_74294815 | 12.97 |
Cfap53 |
cilia and flagella associated protein 53 |
219 |
0.92 |
chr13_105139845_105140060 | 12.83 |
Nt5el |
5' nucleotidase, ecto-like |
57830 |
0.13 |
chr9_35123939_35124137 | 12.81 |
St3gal4 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
4770 |
0.15 |
chr18_32552139_32552325 | 12.65 |
Gypc |
glycophorin C |
7748 |
0.21 |
chr11_115901591_115901903 | 12.61 |
Smim5 |
small integral membrane protein 5 |
1545 |
0.21 |
chr2_75792475_75792662 | 12.60 |
Gm13657 |
predicted gene 13657 |
15380 |
0.13 |
chr4_133237923_133238222 | 12.54 |
Map3k6 |
mitogen-activated protein kinase kinase kinase 6 |
2746 |
0.16 |
chr4_132391174_132391454 | 12.54 |
Phactr4 |
phosphatase and actin regulator 4 |
6885 |
0.09 |
chr6_149193406_149193557 | 12.38 |
Amn1 |
antagonist of mitotic exit network 1 |
4769 |
0.17 |
chr6_83004904_83005252 | 12.14 |
Gm43981 |
predicted gene, 43981 |
13433 |
0.07 |
chr7_106651998_106652182 | 12.10 |
Olfr693 |
olfactory receptor 693 |
26395 |
0.11 |
chr5_96921686_96921899 | 11.96 |
Gm33370 |
predicted gene, 33370 |
383 |
0.52 |
chr7_75611639_75612062 | 11.95 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
10 |
0.98 |
chr10_112002679_112002831 | 11.90 |
Glipr1 |
GLI pathogenesis-related 1 (glioma) |
124 |
0.96 |
chr8_88279719_88279889 | 11.84 |
Adcy7 |
adenylate cyclase 7 |
3188 |
0.24 |
chr4_130715764_130715925 | 11.79 |
Snord85 |
small nucleolar RNA, C/D box 85 |
33790 |
0.11 |
chr13_112748147_112748432 | 11.76 |
Slc38a9 |
solute carrier family 38, member 9 |
12679 |
0.14 |
chr7_75751275_75751440 | 11.75 |
Gm23251 |
predicted gene, 23251 |
6011 |
0.17 |
chr17_5099687_5099851 | 11.73 |
Gm15599 |
predicted gene 15599 |
12341 |
0.25 |
chr3_30765691_30766002 | 11.71 |
Samd7 |
sterile alpha motif domain containing 7 |
9624 |
0.14 |
chrX_13506461_13506671 | 11.66 |
Gm14506 |
predicted gene 14506 |
15533 |
0.17 |
chr7_132686585_132686739 | 11.62 |
Gm15582 |
predicted gene 15582 |
26778 |
0.16 |
chr5_36711866_36712139 | 11.52 |
D5Ertd579e |
DNA segment, Chr 5, ERATO Doi 579, expressed |
15978 |
0.12 |
chr9_65541744_65541992 | 11.51 |
Gm17749 |
predicted gene, 17749 |
12062 |
0.13 |
chr17_46156861_46157153 | 11.50 |
Mad2l1bp |
MAD2L1 binding protein |
3454 |
0.13 |
chr4_133170217_133170368 | 11.50 |
Wasf2 |
WAS protein family, member 2 |
5709 |
0.16 |
chr11_96942296_96942506 | 11.44 |
Pnpo |
pyridoxine 5'-phosphate oxidase |
1378 |
0.21 |
chr15_103453637_103453855 | 11.33 |
Nckap1l |
NCK associated protein 1 like |
48 |
0.96 |
chr11_87751706_87751911 | 11.32 |
Mir142hg |
Mir142 host gene (non-protein coding) |
3769 |
0.1 |
chr6_136683803_136683954 | 11.30 |
Gm4714 |
predicted gene 4714 |
11405 |
0.15 |
chr14_36316822_36316973 | 11.30 |
Gm48663 |
predicted gene, 48663 |
84856 |
0.1 |
chr12_33315305_33315597 | 11.28 |
Atxn7l1 |
ataxin 7-like 1 |
46 |
0.98 |
chr11_87756393_87756787 | 11.25 |
Mir142 |
microRNA 142 |
274 |
0.51 |
chr3_116861553_116862126 | 11.22 |
Frrs1 |
ferric-chelate reductase 1 |
2272 |
0.21 |
chr9_95554705_95555070 | 11.17 |
Gm32281 |
predicted gene, 32281 |
390 |
0.8 |
chr19_7018486_7018933 | 11.15 |
Fermt3 |
fermitin family member 3 |
636 |
0.49 |
chr16_38406899_38407050 | 11.15 |
Pla1a |
phospholipase A1 member A |
10820 |
0.12 |
chr7_75595425_75595576 | 11.12 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
14539 |
0.19 |
chr5_117133755_117134546 | 11.12 |
Taok3 |
TAO kinase 3 |
509 |
0.72 |
chr18_23997003_23997154 | 11.11 |
Zfp35 |
zinc finger protein 35 |
7446 |
0.14 |
chr10_94923268_94923493 | 11.04 |
Plxnc1 |
plexin C1 |
723 |
0.7 |
chr17_26535257_26535653 | 11.04 |
Gm50275 |
predicted gene, 50275 |
2772 |
0.15 |
chr3_106790054_106790205 | 11.02 |
Cd53 |
CD53 antigen |
20 |
0.98 |
chr1_87620165_87620489 | 11.01 |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
15 |
0.97 |
chr16_10689767_10690299 | 11.01 |
Gm15558 |
predicted gene 15558 |
6494 |
0.18 |
chr10_37231911_37232109 | 11.00 |
4930543K20Rik |
RIKEN cDNA 4930543K20 gene |
31738 |
0.19 |
chr8_66438011_66438162 | 10.99 |
Gm15356 |
predicted gene 15356 |
4723 |
0.21 |
chr1_74235993_74236513 | 10.99 |
Arpc2 |
actin related protein 2/3 complex, subunit 2 |
169 |
0.9 |
chr5_106709643_106709821 | 10.98 |
Zfp644 |
zinc finger protein 644 |
12445 |
0.14 |
chr17_29498141_29498452 | 10.88 |
Pim1 |
proviral integration site 1 |
4889 |
0.12 |
chr15_98484581_98484732 | 10.86 |
Lalba |
lactalbumin, alpha |
1935 |
0.15 |
chr6_72389445_72389953 | 10.83 |
Vamp8 |
vesicle-associated membrane protein 8 |
212 |
0.87 |
chr10_115816613_115816915 | 10.79 |
Tspan8 |
tetraspanin 8 |
68 |
0.98 |
chr4_115737400_115738211 | 10.74 |
Efcab14 |
EF-hand calcium binding domain 14 |
25 |
0.97 |
chr6_125572722_125573175 | 10.73 |
Vwf |
Von Willebrand factor |
6697 |
0.22 |
chr10_127204001_127204174 | 10.72 |
Pip4k2c |
phosphatidylinositol-5-phosphate 4-kinase, type II, gamma |
7468 |
0.08 |
chr6_48700494_48700721 | 10.60 |
Gimap6 |
GTPase, IMAP family member 6 |
5629 |
0.08 |
chr11_82845501_82845741 | 10.54 |
Rffl |
ring finger and FYVE like domain containing protein |
471 |
0.71 |
chr16_38287320_38287555 | 10.53 |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
7387 |
0.15 |
chr16_34031697_34031893 | 10.52 |
Kalrn |
kalirin, RhoGEF kinase |
15301 |
0.19 |
chr9_90237307_90237597 | 10.50 |
Gm16200 |
predicted gene 16200 |
15827 |
0.15 |
chr5_72182848_72182999 | 10.50 |
Gm42569 |
predicted gene 42569 |
10635 |
0.17 |
chr8_126591174_126591799 | 10.49 |
Irf2bp2 |
interferon regulatory factor 2 binding protein 2 |
2500 |
0.33 |
chr11_86577252_86577628 | 10.49 |
Mir21a |
microRNA 21a |
6718 |
0.15 |
chr19_24999136_24999583 | 10.48 |
Dock8 |
dedicator of cytokinesis 8 |
175 |
0.95 |
chr14_102827857_102828008 | 10.44 |
Gm34589 |
predicted gene, 34589 |
196 |
0.96 |
chr4_71291873_71292024 | 10.41 |
Gm11229 |
predicted gene 11229 |
6006 |
0.31 |
chr2_79254736_79255032 | 10.41 |
Itga4 |
integrin alpha 4 |
542 |
0.83 |
chr11_110166178_110166329 | 10.39 |
Abca9 |
ATP-binding cassette, sub-family A (ABC1), member 9 |
1802 |
0.44 |
chr4_46040663_46041414 | 10.39 |
Tmod1 |
tropomodulin 1 |
1829 |
0.35 |
chr12_111007759_111007963 | 10.38 |
Gm48631 |
predicted gene, 48631 |
10541 |
0.11 |
chr13_20151004_20151155 | 10.38 |
Elmo1 |
engulfment and cell motility 1 |
34128 |
0.22 |
chr13_23544226_23545176 | 10.38 |
H3c7 |
H3 clustered histone 7 |
649 |
0.31 |
chr11_121239506_121239668 | 10.37 |
Narf |
nuclear prelamin A recognition factor |
2334 |
0.18 |
chr7_3898175_3898326 | 10.37 |
Gm14548 |
predicted gene 14548 |
130 |
0.93 |
chr4_43959953_43960130 | 10.36 |
Glipr2 |
GLI pathogenesis-related 2 |
2349 |
0.22 |
chr3_19634737_19635180 | 10.36 |
1700064H15Rik |
RIKEN cDNA 1700064H15 gene |
6281 |
0.16 |
chr9_110459312_110459495 | 10.36 |
Klhl18 |
kelch-like 18 |
3077 |
0.18 |
chr5_64505724_64505951 | 10.35 |
C030018K13Rik |
RIKEN cDNA C030018K13 gene |
28802 |
0.11 |
chr15_85772274_85772444 | 10.34 |
Ppara |
peroxisome proliferator activated receptor alpha |
145 |
0.95 |
chr5_137115775_137116361 | 10.34 |
Trim56 |
tripartite motif-containing 56 |
139 |
0.93 |
chr6_113668498_113668869 | 10.33 |
Irak2 |
interleukin-1 receptor-associated kinase 2 |
167 |
0.87 |
chr5_134976915_134977068 | 10.28 |
Cldn3 |
claudin 3 |
9223 |
0.08 |
chr8_109436759_109437295 | 10.15 |
Gm23163 |
predicted gene, 23163 |
11283 |
0.22 |
chr7_104288152_104288335 | 10.14 |
Trim5 |
tripartite motif-containing 5 |
149 |
0.89 |
chr5_104958293_104958446 | 10.14 |
Gm43856 |
predicted gene 43856 |
13694 |
0.13 |
chr6_87764003_87764176 | 10.13 |
Gm5879 |
predicted gene 5879 |
2115 |
0.14 |
chr12_32111649_32111803 | 10.09 |
5430401H09Rik |
RIKEN cDNA 5430401H09 gene |
11976 |
0.18 |
chr12_98375326_98375477 | 10.01 |
5330409N07Rik |
RIKEN cDNA 5330409N07 gene |
72933 |
0.08 |
chr8_13594955_13595106 | 9.99 |
Rasa3 |
RAS p21 protein activator 3 |
10992 |
0.17 |
chr5_148886186_148886484 | 9.99 |
Katnal1 |
katanin p60 subunit A-like 1 |
7256 |
0.14 |
chr6_84883761_84883938 | 9.99 |
Exoc6b |
exocyst complex component 6B |
10139 |
0.21 |
chr15_76242988_76243320 | 9.99 |
Parp10 |
poly (ADP-ribose) polymerase family, member 10 |
266 |
0.77 |
chr11_101448301_101448488 | 9.98 |
Ifi35 |
interferon-induced protein 35 |
13 |
0.93 |
chr18_75503434_75503893 | 9.98 |
Gm10532 |
predicted gene 10532 |
10982 |
0.27 |
chr14_70212697_70212892 | 9.91 |
Sorbs3 |
sorbin and SH3 domain containing 3 |
805 |
0.5 |
chr4_132078479_132078695 | 9.90 |
Epb41 |
erythrocyte membrane protein band 4.1 |
3266 |
0.14 |
chr9_111208311_111208469 | 9.86 |
Lrrfip2 |
leucine rich repeat (in FLII) interacting protein 2 |
5803 |
0.19 |
chr10_62506208_62506533 | 9.86 |
Srgn |
serglycin |
1385 |
0.34 |
chr7_103861338_103861749 | 9.84 |
Hbb-y |
hemoglobin Y, beta-like embryonic chain |
8327 |
0.06 |
chr7_104369887_104370038 | 9.82 |
Trim30b |
tripartite motif-containing 30B |
78 |
0.93 |
chr11_90225278_90225429 | 9.81 |
Mmd |
monocyte to macrophage differentiation-associated |
24103 |
0.15 |
chr5_65698076_65698722 | 9.80 |
Pds5a |
PDS5 cohesin associated factor A |
126 |
0.94 |
chr17_49423004_49423196 | 9.75 |
Mocs1 |
molybdenum cofactor synthesis 1 |
5262 |
0.22 |
chr19_10173573_10173745 | 9.73 |
Gm50359 |
predicted gene, 50359 |
2502 |
0.16 |
chr10_89422792_89422943 | 9.73 |
Gas2l3 |
growth arrest-specific 2 like 3 |
10975 |
0.25 |
chr6_136690161_136690312 | 9.73 |
Gm4714 |
predicted gene 4714 |
5047 |
0.18 |
chr2_61514448_61514599 | 9.72 |
Gm22338 |
predicted gene, 22338 |
21757 |
0.24 |
chr3_105892609_105892828 | 9.72 |
Adora3 |
adenosine A3 receptor |
11703 |
0.11 |
chr9_58246140_58246457 | 9.70 |
Pml |
promyelocytic leukemia |
3325 |
0.15 |
chrX_169106002_169106405 | 9.69 |
Gm15261 |
predicted gene 15261 |
333 |
0.91 |
chr9_57800737_57800927 | 9.68 |
Arid3b |
AT rich interactive domain 3B (BRIGHT-like) |
4611 |
0.18 |
chr13_8999532_8999796 | 9.68 |
Gtpbp4 |
GTP binding protein 4 |
3581 |
0.13 |
chr7_142570403_142571198 | 9.67 |
H19 |
H19, imprinted maternally expressed transcript |
5738 |
0.11 |
chr19_6278181_6278879 | 9.65 |
Ehd1 |
EH-domain containing 1 |
1605 |
0.16 |
chr4_58970722_58971018 | 9.64 |
Ptgr1 |
prostaglandin reductase 1 |
16249 |
0.12 |
chr11_95333331_95333502 | 9.62 |
Fam117a |
family with sequence similarity 117, member A |
3602 |
0.15 |
chr8_84702030_84702302 | 9.61 |
Lyl1 |
lymphoblastomic leukemia 1 |
385 |
0.72 |
chr16_35939846_35940048 | 9.59 |
Dtx3l |
deltex 3-like, E3 ubiquitin ligase |
796 |
0.36 |
chr7_104315472_104315664 | 9.57 |
Trim12a |
tripartite motif-containing 12A |
102 |
0.84 |
chr13_5804731_5804882 | 9.55 |
Gm26043 |
predicted gene, 26043 |
17052 |
0.19 |
chr3_118594804_118594955 | 9.55 |
Dpyd |
dihydropyrimidine dehydrogenase |
32693 |
0.16 |
chr11_11684707_11686418 | 9.53 |
Gm11999 |
predicted gene 11999 |
162 |
0.73 |
chr13_74735599_74735790 | 9.53 |
Cast |
calpastatin |
1352 |
0.45 |
chr7_45238735_45238977 | 9.52 |
Cd37 |
CD37 antigen |
16 |
0.92 |
chr10_76488363_76488556 | 9.51 |
Mcm3ap |
minichromosome maintenance complex component 3 associated protein |
7258 |
0.12 |
chr8_11458639_11458838 | 9.51 |
Gm20100 |
predicted gene, 20100 |
1004 |
0.41 |
chr2_128008848_128008999 | 9.48 |
Gm23101 |
predicted gene, 23101 |
81001 |
0.08 |
chr2_162987018_162987169 | 9.46 |
Sgk2 |
serum/glucocorticoid regulated kinase 2 |
237 |
0.89 |
chr1_165766581_165766803 | 9.45 |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
2784 |
0.13 |
chr14_20478827_20479017 | 9.44 |
Anxa7 |
annexin A7 |
986 |
0.42 |
chr9_44767080_44767695 | 9.44 |
Arcn1 |
archain 1 |
411 |
0.47 |
chr11_48901024_48901175 | 9.42 |
Gm5431 |
predicted gene 5431 |
1053 |
0.36 |
chr4_139493640_139493941 | 9.42 |
Ubr4 |
ubiquitin protein ligase E3 component n-recognin 4 |
13410 |
0.17 |
chr8_85142733_85142884 | 9.38 |
Gm45316 |
predicted gene 45316 |
7043 |
0.08 |
chr8_106136769_106137557 | 9.33 |
1810019D21Rik |
RIKEN cDNA 1810019D21 gene |
98 |
0.62 |
chr7_133702126_133702303 | 9.33 |
Uros |
uroporphyrinogen III synthase |
324 |
0.82 |
chr6_123227652_123227803 | 9.31 |
Clec4n |
C-type lectin domain family 4, member n |
2116 |
0.22 |
chr1_191277526_191278108 | 9.30 |
Gm37168 |
predicted gene, 37168 |
10639 |
0.13 |
chr18_64618952_64619176 | 9.30 |
Gm6978 |
predicted gene 6978 |
5965 |
0.17 |
chr8_122700624_122700847 | 9.29 |
Cbfa2t3 |
CBFA2/RUNX1 translocation partner 3 |
1626 |
0.22 |
chr9_70833637_70833964 | 9.23 |
Gm3436 |
predicted pseudogene 3436 |
18776 |
0.18 |
chr2_93461958_93462733 | 9.22 |
Cd82 |
CD82 antigen |
41 |
0.97 |
chr4_41314806_41315174 | 9.19 |
Dcaf12 |
DDB1 and CUL4 associated factor 12 |
101 |
0.94 |
chr8_110217481_110218281 | 9.18 |
Cmtr2 |
cap methyltransferase 2 |
108 |
0.97 |
chr4_129335876_129336054 | 9.18 |
Zbtb8os |
zinc finger and BTB domain containing 8 opposite strand |
47 |
0.9 |
chr9_64830115_64830266 | 9.18 |
Dennd4a |
DENN/MADD domain containing 4A |
18646 |
0.18 |
chr11_11730242_11730393 | 9.16 |
Gm12000 |
predicted gene 12000 |
33878 |
0.14 |
chr2_180236672_180236838 | 9.16 |
Lama5 |
laminin, alpha 5 |
10896 |
0.11 |
chr17_50071266_50071512 | 9.16 |
Rftn1 |
raftlin lipid raft linker 1 |
22943 |
0.18 |
chr7_110840366_110840519 | 9.15 |
Rnf141 |
ring finger protein 141 |
2913 |
0.21 |
chr2_120578359_120578510 | 9.14 |
Snap23 |
synaptosomal-associated protein 23 |
7807 |
0.14 |
chr7_103813259_103814109 | 9.14 |
Hbb-bt |
hemoglobin, beta adult t chain |
312 |
0.71 |
chr2_73056222_73056429 | 9.13 |
Gm13665 |
predicted gene 13665 |
60423 |
0.08 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.1 | 36.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
5.6 | 16.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
5.5 | 16.6 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
4.4 | 17.6 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
4.2 | 12.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
4.2 | 12.5 | GO:0036394 | amylase secretion(GO:0036394) |
3.9 | 19.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
3.8 | 15.0 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
3.7 | 14.9 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
3.7 | 18.5 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
3.7 | 33.2 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
3.7 | 14.8 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
3.7 | 3.7 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
3.7 | 22.1 | GO:0002576 | platelet degranulation(GO:0002576) |
3.7 | 11.0 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
3.5 | 3.5 | GO:1903312 | negative regulation of mRNA metabolic process(GO:1903312) |
3.4 | 10.1 | GO:0045472 | response to ether(GO:0045472) |
3.3 | 13.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
3.2 | 9.7 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
3.1 | 9.4 | GO:0009804 | coumarin metabolic process(GO:0009804) |
3.1 | 9.4 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
3.1 | 9.3 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
3.0 | 12.2 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
2.9 | 8.7 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
2.9 | 2.9 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
2.8 | 2.8 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
2.7 | 8.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
2.5 | 10.1 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
2.5 | 7.5 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
2.5 | 12.3 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
2.5 | 22.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
2.4 | 12.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
2.4 | 12.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
2.4 | 9.6 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
2.4 | 2.4 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
2.4 | 4.8 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
2.4 | 7.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
2.4 | 7.2 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
2.4 | 7.1 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
2.4 | 40.1 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
2.3 | 6.9 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
2.3 | 6.9 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
2.3 | 18.2 | GO:0070922 | small RNA loading onto RISC(GO:0070922) |
2.3 | 2.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
2.3 | 2.3 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
2.2 | 4.5 | GO:0042908 | xenobiotic transport(GO:0042908) |
2.2 | 6.7 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
2.1 | 6.4 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
2.1 | 6.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
2.1 | 6.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
2.1 | 8.4 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
2.1 | 16.5 | GO:0001771 | immunological synapse formation(GO:0001771) |
2.1 | 6.2 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
2.1 | 6.2 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
2.0 | 12.3 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
2.0 | 8.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
2.0 | 8.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
2.0 | 8.0 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
2.0 | 8.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
2.0 | 6.0 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
2.0 | 29.6 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
2.0 | 3.9 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.9 | 13.2 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
1.9 | 5.7 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
1.9 | 7.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.8 | 11.0 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
1.8 | 9.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
1.8 | 5.5 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
1.8 | 7.3 | GO:0008228 | opsonization(GO:0008228) |
1.8 | 7.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.8 | 9.1 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
1.8 | 14.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
1.8 | 7.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
1.8 | 5.4 | GO:0034214 | protein hexamerization(GO:0034214) |
1.8 | 5.4 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
1.8 | 7.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
1.8 | 5.3 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
1.8 | 5.3 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
1.7 | 5.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
1.7 | 10.3 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
1.7 | 8.6 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
1.7 | 6.8 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
1.7 | 3.4 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
1.7 | 5.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.7 | 21.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.6 | 4.9 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
1.6 | 1.6 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.6 | 7.9 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
1.6 | 4.7 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.6 | 7.8 | GO:0080009 | mRNA methylation(GO:0080009) |
1.5 | 4.6 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
1.5 | 4.6 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.5 | 4.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
1.5 | 5.9 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
1.5 | 5.9 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
1.5 | 4.5 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.5 | 7.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
1.4 | 4.3 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.4 | 5.7 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
1.4 | 7.1 | GO:0051013 | microtubule severing(GO:0051013) |
1.4 | 7.1 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.4 | 13.9 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
1.4 | 5.5 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.4 | 5.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
1.4 | 4.1 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.4 | 4.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
1.3 | 4.0 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.3 | 13.3 | GO:0034063 | stress granule assembly(GO:0034063) |
1.3 | 4.0 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
1.3 | 5.3 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
1.3 | 9.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
1.3 | 3.9 | GO:0002432 | granuloma formation(GO:0002432) |
1.3 | 1.3 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
1.3 | 11.7 | GO:2000104 | negative regulation of DNA-dependent DNA replication(GO:2000104) |
1.3 | 3.9 | GO:0071335 | hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) |
1.3 | 7.8 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
1.3 | 3.9 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
1.3 | 3.8 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
1.3 | 9.0 | GO:0033572 | transferrin transport(GO:0033572) |
1.3 | 2.5 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
1.3 | 2.5 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
1.3 | 5.0 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
1.3 | 2.5 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
1.2 | 3.7 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
1.2 | 2.5 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
1.2 | 2.5 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
1.2 | 4.9 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
1.2 | 1.2 | GO:0061450 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) positive regulation of trophoblast cell migration(GO:1901165) |
1.2 | 4.9 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
1.2 | 1.2 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
1.2 | 3.7 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
1.2 | 3.6 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
1.2 | 3.6 | GO:0040031 | snRNA modification(GO:0040031) |
1.2 | 1.2 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
1.2 | 3.6 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
1.2 | 5.9 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
1.2 | 3.6 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
1.2 | 2.4 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
1.2 | 1.2 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.2 | 3.5 | GO:0010046 | response to mycotoxin(GO:0010046) |
1.2 | 6.9 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
1.1 | 3.4 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
1.1 | 4.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.1 | 3.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.1 | 1.1 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
1.1 | 4.5 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.1 | 15.7 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
1.1 | 14.5 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
1.1 | 3.3 | GO:0070827 | chromatin maintenance(GO:0070827) |
1.1 | 1.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
1.1 | 7.7 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
1.1 | 5.4 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
1.1 | 5.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.1 | 1.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
1.1 | 5.4 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.1 | 2.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
1.1 | 1.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
1.1 | 3.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.1 | 8.6 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
1.1 | 5.3 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
1.1 | 4.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.1 | 2.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.1 | 5.3 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
1.0 | 5.2 | GO:0016139 | glycoside catabolic process(GO:0016139) |
1.0 | 1.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
1.0 | 3.1 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
1.0 | 4.1 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
1.0 | 4.1 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
1.0 | 1.0 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
1.0 | 3.1 | GO:0019042 | viral latency(GO:0019042) |
1.0 | 17.4 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
1.0 | 2.0 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
1.0 | 2.0 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
1.0 | 4.0 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
1.0 | 3.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.0 | 6.0 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
1.0 | 1.0 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
1.0 | 6.0 | GO:0051639 | actin filament network formation(GO:0051639) |
1.0 | 2.0 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
1.0 | 2.0 | GO:0072592 | oxygen metabolic process(GO:0072592) |
1.0 | 2.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.0 | 18.7 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
1.0 | 3.9 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
1.0 | 1.0 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
1.0 | 13.6 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
1.0 | 1.9 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
1.0 | 8.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.0 | 1.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
1.0 | 4.8 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
1.0 | 1.0 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
1.0 | 2.9 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
1.0 | 1.0 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
1.0 | 1.9 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
1.0 | 1.9 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
1.0 | 1.9 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
1.0 | 4.8 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
1.0 | 1.9 | GO:0046104 | thymidine metabolic process(GO:0046104) |
1.0 | 1.9 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
1.0 | 5.8 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
1.0 | 3.8 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
1.0 | 1.9 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
1.0 | 3.8 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.0 | 5.7 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
1.0 | 1.9 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
1.0 | 1.0 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.9 | 1.9 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.9 | 2.8 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.9 | 0.9 | GO:1904193 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.9 | 12.1 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.9 | 4.7 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.9 | 2.8 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.9 | 0.9 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.9 | 1.9 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.9 | 2.8 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.9 | 0.9 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
0.9 | 7.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.9 | 0.9 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.9 | 3.6 | GO:0051031 | tRNA transport(GO:0051031) |
0.9 | 4.5 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.9 | 0.9 | GO:0030575 | nuclear body organization(GO:0030575) |
0.9 | 3.6 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.9 | 18.8 | GO:0034340 | response to type I interferon(GO:0034340) |
0.9 | 3.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.9 | 10.5 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.9 | 2.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.9 | 0.9 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.9 | 0.9 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.9 | 5.2 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.9 | 3.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.8 | 6.8 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.8 | 5.9 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.8 | 1.7 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.8 | 1.7 | GO:0032439 | endosome localization(GO:0032439) |
0.8 | 5.9 | GO:0045649 | regulation of macrophage differentiation(GO:0045649) |
0.8 | 2.5 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.8 | 4.2 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.8 | 1.6 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.8 | 2.5 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.8 | 4.1 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.8 | 6.6 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.8 | 2.5 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.8 | 15.5 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.8 | 4.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.8 | 5.7 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.8 | 4.9 | GO:2000674 | regulation of type B pancreatic cell apoptotic process(GO:2000674) |
0.8 | 4.9 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.8 | 10.6 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.8 | 4.9 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.8 | 2.4 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.8 | 3.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.8 | 4.8 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.8 | 2.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.8 | 3.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.8 | 1.6 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.8 | 3.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.8 | 0.8 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.8 | 5.6 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.8 | 4.8 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.8 | 0.8 | GO:1902563 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
0.8 | 8.0 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.8 | 4.8 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.8 | 1.6 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.8 | 0.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.8 | 3.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.8 | 2.4 | GO:0051593 | response to folic acid(GO:0051593) |
0.8 | 1.6 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.8 | 5.5 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.8 | 4.7 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.8 | 0.8 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
0.8 | 11.0 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.8 | 1.6 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.8 | 7.0 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.8 | 2.3 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.8 | 1.5 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.8 | 15.4 | GO:0006301 | postreplication repair(GO:0006301) |
0.8 | 2.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.8 | 4.6 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.8 | 3.8 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.8 | 4.6 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.8 | 3.8 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.8 | 13.7 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.8 | 1.5 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.8 | 3.8 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.8 | 2.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.7 | 6.7 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.7 | 2.2 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.7 | 3.0 | GO:0044351 | macropinocytosis(GO:0044351) |
0.7 | 1.5 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.7 | 2.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.7 | 2.2 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.7 | 2.2 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.7 | 1.5 | GO:0002215 | defense response to nematode(GO:0002215) |
0.7 | 1.5 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.7 | 2.9 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.7 | 9.5 | GO:0006465 | signal peptide processing(GO:0006465) |
0.7 | 4.3 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.7 | 2.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.7 | 4.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.7 | 0.7 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.7 | 1.4 | GO:0072683 | T cell extravasation(GO:0072683) |
0.7 | 5.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.7 | 2.9 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.7 | 2.9 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.7 | 2.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.7 | 2.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.7 | 3.6 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.7 | 2.9 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.7 | 2.8 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.7 | 5.0 | GO:0015825 | L-serine transport(GO:0015825) |
0.7 | 2.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.7 | 2.8 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.7 | 2.1 | GO:0042117 | monocyte activation(GO:0042117) |
0.7 | 1.4 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.7 | 2.8 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.7 | 4.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.7 | 0.7 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.7 | 0.7 | GO:0003134 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
0.7 | 0.7 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.7 | 2.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.7 | 0.7 | GO:0015809 | arginine transport(GO:0015809) |
0.7 | 3.4 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.7 | 1.4 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.7 | 2.7 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.7 | 4.8 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.7 | 1.4 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.7 | 0.7 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.7 | 3.4 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.7 | 2.7 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.7 | 4.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.7 | 2.0 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.7 | 2.0 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.7 | 4.1 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.7 | 8.1 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.7 | 6.8 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.7 | 5.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.7 | 0.7 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.7 | 21.6 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.7 | 1.3 | GO:1902896 | terminal web assembly(GO:1902896) |
0.7 | 1.3 | GO:0035973 | aggrephagy(GO:0035973) |
0.7 | 0.7 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.7 | 3.3 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.7 | 4.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.7 | 2.7 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.7 | 5.3 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.7 | 4.0 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.7 | 0.7 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.7 | 2.0 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.7 | 2.0 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.7 | 0.7 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.7 | 2.0 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.7 | 7.9 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.7 | 2.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.7 | 1.3 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.7 | 1.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.6 | 1.9 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.6 | 6.5 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.6 | 2.6 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.6 | 3.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.6 | 1.9 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.6 | 5.8 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.6 | 1.3 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.6 | 3.2 | GO:0018101 | protein citrullination(GO:0018101) |
0.6 | 1.3 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.6 | 3.8 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.6 | 14.7 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.6 | 1.9 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.6 | 4.4 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.6 | 1.9 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.6 | 5.0 | GO:0050779 | RNA destabilization(GO:0050779) |
0.6 | 2.5 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.6 | 5.6 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.6 | 8.6 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.6 | 1.8 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.6 | 1.8 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.6 | 4.3 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.6 | 6.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.6 | 2.4 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.6 | 1.8 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.6 | 1.8 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.6 | 1.2 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.6 | 6.6 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.6 | 2.4 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.6 | 4.8 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.6 | 11.9 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.6 | 1.2 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.6 | 1.2 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.6 | 1.8 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.6 | 3.6 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.6 | 1.2 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.6 | 16.5 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.6 | 2.4 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.6 | 2.4 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.6 | 2.9 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.6 | 7.0 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.6 | 1.8 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.6 | 4.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.6 | 0.6 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.6 | 1.7 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.6 | 1.2 | GO:0010885 | regulation of cholesterol storage(GO:0010885) |
0.6 | 1.7 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.6 | 4.0 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.6 | 1.1 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.6 | 2.9 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.6 | 4.6 | GO:0097320 | membrane tubulation(GO:0097320) |
0.6 | 1.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.6 | 5.7 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.6 | 5.7 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.6 | 6.8 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.6 | 6.8 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.6 | 0.6 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.6 | 1.7 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.6 | 1.1 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.6 | 1.7 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.6 | 1.1 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.6 | 2.8 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.6 | 1.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.6 | 5.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.6 | 0.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.6 | 2.8 | GO:0018904 | ether metabolic process(GO:0018904) |
0.6 | 6.1 | GO:0051601 | exocyst localization(GO:0051601) |
0.6 | 2.8 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.5 | 1.1 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.5 | 2.7 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.5 | 0.5 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.5 | 2.2 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.5 | 1.6 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.5 | 1.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.5 | 1.1 | GO:0015886 | heme transport(GO:0015886) |
0.5 | 1.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.5 | 1.6 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.5 | 0.5 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.5 | 14.0 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.5 | 1.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.5 | 1.6 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.5 | 2.1 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.5 | 0.5 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.5 | 6.4 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.5 | 1.6 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.5 | 0.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.5 | 2.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.5 | 1.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.5 | 0.5 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.5 | 1.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.5 | 1.1 | GO:0000087 | mitotic M phase(GO:0000087) |
0.5 | 3.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.5 | 3.2 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.5 | 1.0 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.5 | 2.1 | GO:0018214 | protein carboxylation(GO:0018214) |
0.5 | 11.5 | GO:0070527 | platelet aggregation(GO:0070527) |
0.5 | 3.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.5 | 0.5 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.5 | 3.1 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.5 | 3.6 | GO:0010226 | response to lithium ion(GO:0010226) |
0.5 | 0.5 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.5 | 0.5 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.5 | 1.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.5 | 3.1 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.5 | 1.5 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) terpenoid biosynthetic process(GO:0016114) |
0.5 | 4.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.5 | 0.5 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.5 | 0.5 | GO:1903726 | negative regulation of phospholipid metabolic process(GO:1903726) |
0.5 | 0.5 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.5 | 1.0 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.5 | 0.5 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.5 | 1.0 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.5 | 1.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.5 | 2.5 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.5 | 3.5 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.5 | 1.5 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.5 | 10.5 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.5 | 5.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.5 | 1.5 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.5 | 1.5 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.5 | 1.0 | GO:0002347 | response to tumor cell(GO:0002347) |
0.5 | 0.5 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.5 | 2.0 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.5 | 1.0 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.5 | 4.9 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.5 | 1.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.5 | 1.0 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.5 | 4.0 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.5 | 2.5 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.5 | 17.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.5 | 2.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.5 | 1.0 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.5 | 1.5 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.5 | 1.5 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.5 | 3.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.5 | 1.5 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.5 | 1.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.5 | 6.3 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.5 | 1.4 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.5 | 1.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.5 | 0.5 | GO:2000109 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) negative regulation of macrophage apoptotic process(GO:2000110) |
0.5 | 0.5 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.5 | 0.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.5 | 0.5 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.5 | 0.5 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.5 | 1.0 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.5 | 1.0 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.5 | 1.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.5 | 2.8 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.5 | 0.9 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.5 | 2.8 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.5 | 0.9 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.5 | 3.8 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.5 | 6.6 | GO:0008272 | sulfate transport(GO:0008272) |
0.5 | 1.9 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.5 | 0.5 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.5 | 1.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.5 | 1.9 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.5 | 4.7 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.5 | 1.4 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.5 | 1.4 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.5 | 2.8 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.5 | 1.9 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.5 | 4.6 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.5 | 2.8 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.5 | 0.9 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.5 | 2.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.5 | 2.3 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.5 | 5.0 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.5 | 1.4 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.4 | 3.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.4 | 3.6 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.4 | 2.7 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.4 | 2.2 | GO:0001842 | neural fold formation(GO:0001842) |
0.4 | 2.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.4 | 0.4 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.4 | 0.9 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.4 | 1.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.4 | 1.8 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.4 | 1.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.4 | 1.8 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.4 | 1.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.4 | 1.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.4 | 5.3 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.4 | 0.9 | GO:0048535 | lymph node development(GO:0048535) |
0.4 | 1.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.4 | 2.2 | GO:0033762 | response to glucagon(GO:0033762) |
0.4 | 1.3 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.4 | 0.9 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.4 | 4.4 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.4 | 1.3 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.4 | 0.4 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.4 | 0.9 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.4 | 3.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.4 | 1.7 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
0.4 | 0.9 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.4 | 3.0 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.4 | 1.3 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.4 | 2.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.4 | 1.3 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.4 | 1.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.4 | 0.4 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.4 | 1.3 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.4 | 3.8 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.4 | 8.1 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.4 | 3.0 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.4 | 1.7 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.4 | 0.9 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.4 | 1.3 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.4 | 5.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.4 | 10.6 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.4 | 2.5 | GO:0006907 | pinocytosis(GO:0006907) |
0.4 | 4.2 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.4 | 0.8 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.4 | 6.3 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.4 | 0.4 | GO:0072718 | response to cisplatin(GO:0072718) |
0.4 | 0.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.4 | 0.4 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.4 | 13.8 | GO:0045576 | mast cell activation(GO:0045576) |
0.4 | 2.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.4 | 0.8 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.4 | 0.8 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.4 | 0.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.4 | 5.8 | GO:0051923 | sulfation(GO:0051923) |
0.4 | 0.4 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.4 | 1.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.4 | 1.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.4 | 0.4 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.4 | 0.8 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.4 | 1.2 | GO:1903960 | negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
0.4 | 0.4 | GO:0061117 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
0.4 | 0.4 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.4 | 2.0 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.4 | 0.8 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.4 | 1.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.4 | 2.4 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.4 | 1.6 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.4 | 1.2 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.4 | 1.2 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.4 | 0.8 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.4 | 1.6 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.4 | 0.4 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.4 | 1.2 | GO:0007525 | somatic muscle development(GO:0007525) |
0.4 | 1.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.4 | 4.4 | GO:0006298 | mismatch repair(GO:0006298) |
0.4 | 0.8 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.4 | 0.4 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.4 | 3.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.4 | 2.8 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.4 | 9.1 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.4 | 0.4 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.4 | 3.6 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.4 | 1.2 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.4 | 1.2 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.4 | 1.2 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.4 | 3.5 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.4 | 2.0 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.4 | 1.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.4 | 0.4 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.4 | 0.4 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) |
0.4 | 0.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.4 | 0.4 | GO:0033045 | regulation of sister chromatid segregation(GO:0033045) |
0.4 | 2.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.4 | 1.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.4 | 1.5 | GO:0007097 | nuclear migration(GO:0007097) |
0.4 | 0.4 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.4 | 1.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.4 | 5.4 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.4 | 2.3 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.4 | 1.9 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.4 | 3.8 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.4 | 0.8 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.4 | 1.5 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.4 | 0.4 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.4 | 3.0 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.4 | 0.8 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.4 | 0.4 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.4 | 10.9 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.4 | 0.7 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.4 | 1.5 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.4 | 1.5 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.4 | 1.5 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.4 | 2.2 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.4 | 0.4 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.4 | 1.8 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.4 | 3.7 | GO:0070266 | necroptotic process(GO:0070266) |
0.4 | 1.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.4 | 0.7 | GO:0032782 | bile acid secretion(GO:0032782) |
0.4 | 0.7 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.4 | 1.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 4.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.4 | 1.5 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.4 | 4.3 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.4 | 2.5 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.4 | 2.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.4 | 1.8 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.4 | 1.4 | GO:0046415 | urate metabolic process(GO:0046415) |
0.4 | 1.4 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.4 | 0.4 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.4 | 2.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.4 | 0.4 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.4 | 1.4 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.4 | 7.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.4 | 1.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.4 | 0.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.4 | 1.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.4 | 1.4 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.4 | 1.1 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.4 | 1.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.4 | 0.7 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.4 | 3.9 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.4 | 1.4 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.4 | 1.4 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.4 | 2.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.4 | 1.1 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.4 | 0.7 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.4 | 4.9 | GO:0044804 | nucleophagy(GO:0044804) |
0.3 | 0.7 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.3 | 1.4 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.3 | 1.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.3 | 0.3 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.3 | 0.7 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.3 | 1.7 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.3 | 0.3 | GO:0071305 | cellular response to vitamin(GO:0071295) cellular response to vitamin D(GO:0071305) |
0.3 | 0.3 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.3 | 0.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 0.7 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.3 | 8.2 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.3 | 2.0 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.3 | 0.3 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 0.7 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.3 | 0.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.3 | 6.8 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.3 | 1.4 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.3 | 6.4 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.3 | 1.3 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.3 | 3.7 | GO:0032642 | regulation of chemokine production(GO:0032642) |
0.3 | 1.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.3 | 5.0 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 0.7 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.3 | 1.3 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 0.7 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.3 | 1.0 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.3 | 1.3 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.3 | 0.7 | GO:0030576 | Cajal body organization(GO:0030576) |
0.3 | 1.0 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.3 | 1.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.3 | 1.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 0.7 | GO:1900040 | interleukin-2 secretion(GO:0070970) regulation of interleukin-2 secretion(GO:1900040) |
0.3 | 0.3 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.3 | 1.6 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.3 | 0.3 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.3 | 0.7 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.3 | 3.9 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.3 | 0.3 | GO:0003128 | heart field specification(GO:0003128) |
0.3 | 2.6 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.3 | 1.3 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.3 | 0.6 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.3 | 1.6 | GO:0002467 | germinal center formation(GO:0002467) |
0.3 | 1.0 | GO:0046697 | decidualization(GO:0046697) |
0.3 | 1.0 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.3 | 0.3 | GO:0032570 | response to progesterone(GO:0032570) |
0.3 | 2.2 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.3 | 1.0 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.3 | 1.6 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.3 | 1.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.3 | 8.0 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.3 | 0.6 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.3 | 1.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.3 | 0.3 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.3 | 3.5 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.3 | 0.6 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.3 | 0.6 | GO:0046850 | regulation of bone remodeling(GO:0046850) |
0.3 | 0.6 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.3 | 1.3 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.3 | 1.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.3 | 0.3 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.3 | 0.3 | GO:0044321 | response to leptin(GO:0044321) |
0.3 | 1.6 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.3 | 1.5 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.3 | 10.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.3 | 3.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.3 | 0.3 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.3 | 6.8 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.3 | 0.3 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
0.3 | 0.3 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.3 | 0.9 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 2.8 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.3 | 4.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 0.3 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.3 | 0.3 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.3 | 0.6 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.3 | 0.9 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.3 | 0.3 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.3 | 5.5 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.3 | 1.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.3 | 0.9 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 1.2 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.3 | 0.6 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.3 | 1.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.3 | 2.4 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.3 | 0.3 | GO:0003099 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) regulation of the force of heart contraction by chemical signal(GO:0003057) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.3 | 0.3 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.3 | 1.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.3 | 1.8 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.3 | 1.8 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.3 | 15.4 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.3 | 2.7 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.3 | 2.7 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.3 | 2.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.3 | 0.3 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.3 | 1.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.3 | 0.9 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.3 | 0.6 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.3 | 0.9 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.3 | 0.6 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.3 | 1.2 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.3 | 0.6 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.3 | 0.3 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.3 | 0.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.3 | 1.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.3 | 0.9 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.3 | 1.4 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.3 | 9.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.3 | 2.3 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.3 | 0.9 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.3 | 0.6 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.3 | 0.9 | GO:1903671 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
0.3 | 0.9 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.3 | 1.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.3 | 0.9 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.3 | 0.6 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.3 | 3.7 | GO:0006953 | acute-phase response(GO:0006953) |
0.3 | 1.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.3 | 0.9 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 0.3 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.3 | 0.6 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.3 | 4.5 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.3 | 0.6 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.3 | 2.0 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.3 | 2.0 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 0.8 | GO:0035425 | autocrine signaling(GO:0035425) |
0.3 | 0.6 | GO:0070627 | ferrous iron import(GO:0070627) |
0.3 | 15.1 | GO:0007030 | Golgi organization(GO:0007030) |
0.3 | 1.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.3 | 2.0 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.3 | 7.8 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.3 | 2.0 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.3 | 2.5 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.3 | 2.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.3 | 0.3 | GO:0051775 | response to redox state(GO:0051775) |
0.3 | 2.8 | GO:0035196 | production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
0.3 | 0.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 0.8 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.3 | 4.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.3 | 0.5 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.3 | 0.5 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.3 | 0.3 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.3 | 0.3 | GO:0032329 | serine transport(GO:0032329) |
0.3 | 1.4 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.3 | 0.3 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.3 | 0.8 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.3 | 1.4 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.3 | 1.4 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.3 | 4.1 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.3 | 0.5 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.3 | 0.5 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.3 | 1.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.3 | 0.8 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.3 | 0.8 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.3 | 0.8 | GO:0071569 | protein ufmylation(GO:0071569) |
0.3 | 0.3 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.3 | 4.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.3 | 3.7 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.3 | 0.3 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.3 | 0.8 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.3 | 1.9 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.3 | 0.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 0.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.3 | 0.5 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.3 | 0.3 | GO:0060416 | response to growth hormone(GO:0060416) |
0.3 | 0.5 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.3 | 2.1 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.3 | 0.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.3 | 1.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.3 | 0.3 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.3 | 0.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 0.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.3 | 1.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 0.8 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.3 | 0.3 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.3 | 0.8 | GO:0030220 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.3 | 0.5 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.3 | 1.5 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.3 | 0.8 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.3 | 0.3 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.3 | 0.3 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.3 | 0.3 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.3 | 2.3 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.3 | 0.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 | 3.5 | GO:0045954 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.3 | 0.5 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.3 | 1.5 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.3 | 3.0 | GO:0043489 | RNA stabilization(GO:0043489) |
0.3 | 2.0 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 0.5 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.2 | 2.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.5 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 0.7 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 0.7 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 0.2 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.2 | 2.5 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.2 | 0.5 | GO:0010039 | response to iron ion(GO:0010039) |
0.2 | 8.3 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.2 | 0.7 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.2 | 1.0 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 7.5 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 1.0 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.2 | 0.2 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.2 | 0.5 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.2 | 0.5 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 5.3 | GO:0050715 | positive regulation of cytokine secretion(GO:0050715) |
0.2 | 1.2 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.2 | 0.7 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 1.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 1.4 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.2 | 0.7 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.7 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.2 | 1.7 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.2 | 1.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 0.5 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.2 | 1.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.5 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.2 | 0.7 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.2 | 0.7 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.2 | 0.5 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.2 | 0.7 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.7 | GO:1902267 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.2 | 0.2 | GO:0000212 | meiotic spindle organization(GO:0000212) positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.2 | 0.7 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 0.5 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 2.1 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) |
0.2 | 0.5 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.2 | 3.5 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.2 | 1.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 0.7 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.2 | 1.2 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.2 | 0.9 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 2.1 | GO:0033627 | cell adhesion mediated by integrin(GO:0033627) |
0.2 | 4.1 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.2 | 3.9 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.2 | 0.2 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.2 | 1.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 0.5 | GO:0090186 | regulation of pancreatic juice secretion(GO:0090186) |
0.2 | 0.5 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 0.7 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.7 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.2 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.2 | 0.7 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.2 | 0.2 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.2 | 0.5 | GO:0030421 | defecation(GO:0030421) |
0.2 | 1.8 | GO:0070166 | enamel mineralization(GO:0070166) |
0.2 | 0.9 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.2 | 1.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 0.2 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.2 | 1.1 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.2 | 0.7 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.2 | 0.2 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.2 | 3.6 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.2 | 0.4 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.2 | 0.4 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 0.2 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.2 | 2.7 | GO:0031167 | rRNA methylation(GO:0031167) |
0.2 | 0.4 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.2 | 2.9 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 2.6 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 0.4 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.2 | 1.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 2.9 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 0.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.2 | 0.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 0.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 4.8 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 1.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 0.4 | GO:0070417 | cellular response to cold(GO:0070417) |
0.2 | 0.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.2 | 0.2 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.2 | 1.3 | GO:0006228 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) |
0.2 | 0.4 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.2 | 0.2 | GO:0003032 | detection of oxygen(GO:0003032) regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.2 | 0.4 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 0.4 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.2 | 1.3 | GO:0045176 | apical protein localization(GO:0045176) |
0.2 | 0.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.2 | 0.4 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.2 | 1.5 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.2 | 0.6 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.2 | 0.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 1.0 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.2 | 0.2 | GO:0051882 | mitochondrial depolarization(GO:0051882) |
0.2 | 0.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 0.6 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 0.6 | GO:0009219 | pyrimidine deoxyribonucleotide metabolic process(GO:0009219) deoxyribonucleotide catabolic process(GO:0009264) deoxyribose phosphate catabolic process(GO:0046386) |
0.2 | 1.2 | GO:0046688 | response to copper ion(GO:0046688) |
0.2 | 0.6 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.2 | 1.2 | GO:0031639 | plasminogen activation(GO:0031639) |
0.2 | 0.2 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.2 | 1.0 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 0.2 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.2 | 2.9 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.2 | 0.6 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.2 | 2.4 | GO:0032210 | regulation of telomere maintenance via telomerase(GO:0032210) |
0.2 | 0.8 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.2 | 0.4 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.2 | 0.6 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 0.8 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 0.8 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 2.6 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.2 | 0.4 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 0.6 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.2 | 0.6 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.2 | 0.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.2 | 0.4 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.2 | 0.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.2 | 1.4 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 0.2 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 1.2 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.2 | 0.2 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.2 | 0.4 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.2 | 0.6 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.6 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.2 | 3.5 | GO:0016575 | histone deacetylation(GO:0016575) |
0.2 | 0.4 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.2 | 2.0 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.2 | 0.2 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.2 | 0.2 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.2 | 9.3 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 5.6 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.2 | 1.7 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.2 | 0.2 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.2 | 5.6 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.2 | 0.4 | GO:0060022 | hard palate development(GO:0060022) |
0.2 | 0.4 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.2 | 0.2 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.2 | 1.9 | GO:0002021 | response to dietary excess(GO:0002021) |
0.2 | 3.0 | GO:0043297 | apical junction assembly(GO:0043297) |
0.2 | 0.8 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.2 | 0.9 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 0.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.2 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 0.7 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.2 | 2.8 | GO:0001510 | RNA methylation(GO:0001510) |
0.2 | 0.2 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 5.5 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.2 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 0.5 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.2 | 0.7 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.2 | 0.2 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.2 | 4.0 | GO:0035904 | aorta development(GO:0035904) |
0.2 | 1.4 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.2 | 0.5 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 1.4 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.2 | 2.0 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.2 | 1.1 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.2 | 1.6 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.2 | 0.2 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 1.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 0.5 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.2 | 0.4 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.2 | 0.2 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.4 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 0.7 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.2 | 0.7 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 0.9 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 1.8 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
0.2 | 2.5 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.2 | 0.5 | GO:0034505 | tooth mineralization(GO:0034505) |
0.2 | 2.3 | GO:0019915 | lipid storage(GO:0019915) |
0.2 | 2.1 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.2 | 0.5 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 1.2 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.2 | 0.5 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.2 | 0.9 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.2 | 0.2 | GO:0015669 | gas transport(GO:0015669) |
0.2 | 0.9 | GO:0071435 | potassium ion export(GO:0071435) |
0.2 | 0.7 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.2 | 1.4 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.2 | 0.7 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 0.7 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 0.3 | GO:1902932 | positive regulation of alcohol biosynthetic process(GO:1902932) |
0.2 | 0.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.2 | 2.9 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.2 | 1.3 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.2 | 0.3 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.2 | 0.8 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 0.3 | GO:1901203 | positive regulation of extracellular matrix assembly(GO:1901203) |
0.2 | 0.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 0.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.2 | 0.8 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.2 | 0.2 | GO:0044117 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.2 | 1.2 | GO:0030261 | chromosome condensation(GO:0030261) |
0.2 | 9.8 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.2 | 0.3 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.2 | 0.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.2 | 0.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 3.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.2 | 1.7 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.2 | 0.5 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.2 | 0.3 | GO:0009624 | response to nematode(GO:0009624) |
0.2 | 1.7 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 2.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 2.8 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.2 | 0.7 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.2 | 2.4 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.2 | 3.3 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
0.2 | 0.8 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 0.2 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.2 | 2.3 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 4.7 | GO:0003341 | cilium movement(GO:0003341) |
0.2 | 0.2 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.2 | 0.3 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.2 | 0.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 0.3 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.2 | 0.5 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.2 | 0.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.2 | GO:0042701 | progesterone secretion(GO:0042701) |
0.2 | 0.5 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.2 | 0.8 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.2 | 0.2 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.2 | 0.8 | GO:0051236 | establishment of RNA localization(GO:0051236) |
0.2 | 0.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 1.9 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
0.2 | 0.8 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 0.2 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.2 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 0.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.2 | 1.4 | GO:1903322 | positive regulation of protein modification by small protein conjugation or removal(GO:1903322) |
0.2 | 0.8 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 6.2 | GO:0051225 | spindle assembly(GO:0051225) |
0.2 | 0.2 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.2 | 0.2 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.2 | 3.3 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.2 | 0.5 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.2 | 0.2 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.2 | 0.5 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.2 | 0.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 12.6 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.2 | 0.6 | GO:0034311 | diol metabolic process(GO:0034311) |
0.2 | 0.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 1.4 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.2 | 1.7 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.2 | 0.6 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.2 | 0.5 | GO:0006056 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
0.2 | 0.6 | GO:0033522 | histone H2A ubiquitination(GO:0033522) histone H2A monoubiquitination(GO:0035518) |
0.2 | 0.3 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.2 | 0.2 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 10.8 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.1 | 0.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.7 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.1 | 1.2 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 1.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.3 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 7.5 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 0.1 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.1 | 0.1 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.1 | 0.3 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.1 | 0.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.6 | GO:1902116 | negative regulation of organelle assembly(GO:1902116) |
0.1 | 0.6 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 1.1 | GO:0032400 | melanosome localization(GO:0032400) |
0.1 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.7 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.1 | GO:0060426 | lung vasculature development(GO:0060426) |
0.1 | 0.4 | GO:0019320 | hexose catabolic process(GO:0019320) |
0.1 | 0.3 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.1 | 0.3 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 2.9 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 3.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.1 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.1 | 0.6 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 1.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 2.3 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.7 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.1 | 0.3 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.1 | 0.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.4 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.7 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.7 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.8 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.1 | 0.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 0.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 2.9 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.4 | GO:0060068 | vagina development(GO:0060068) |
0.1 | 0.3 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 1.6 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 1.0 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.1 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.1 | 0.1 | GO:1902837 | amino acid import into cell(GO:1902837) L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.1 | 0.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.8 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.4 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.8 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.4 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.4 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.6 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.5 | GO:0050802 | circadian sleep/wake cycle, sleep(GO:0050802) |
0.1 | 0.4 | GO:0072429 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.4 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.1 | GO:2000136 | regulation of cell proliferation involved in heart morphogenesis(GO:2000136) |
0.1 | 0.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.6 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.1 | 0.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.5 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.1 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.1 | 0.2 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.1 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.9 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
0.1 | 0.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.5 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.7 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.2 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.2 | GO:0045023 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.1 | 0.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.6 | GO:0002385 | mucosal immune response(GO:0002385) |
0.1 | 0.5 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.1 | 0.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 3.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.1 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.1 | 0.6 | GO:0042159 | protein depalmitoylation(GO:0002084) lipoprotein catabolic process(GO:0042159) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.6 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.7 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.5 | GO:0070542 | response to fatty acid(GO:0070542) |
0.1 | 1.0 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.1 | 0.7 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.4 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.6 | GO:0099622 | cardiac muscle cell membrane repolarization(GO:0099622) |
0.1 | 0.2 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.2 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.1 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.1 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.1 | 1.1 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.1 | 0.3 | GO:0044062 | regulation of excretion(GO:0044062) |
0.1 | 0.4 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
0.1 | 1.0 | GO:0030104 | water homeostasis(GO:0030104) |
0.1 | 0.5 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.1 | 1.4 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.5 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.1 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.1 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.1 | 0.2 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 1.2 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 0.1 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.5 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.1 | 1.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.7 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 1.4 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.3 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.1 | GO:0010324 | membrane invagination(GO:0010324) |
0.1 | 0.1 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.2 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.3 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 2.9 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 0.3 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.1 | 0.1 | GO:1903299 | regulation of hexokinase activity(GO:1903299) |
0.1 | 0.3 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 0.1 | GO:0032200 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.1 | 0.1 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.8 | GO:0042308 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein import(GO:1904590) |
0.1 | 0.4 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 1.2 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.4 | GO:0052805 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) imidazole-containing compound metabolic process(GO:0052803) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 0.1 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.1 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.2 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 2.7 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.1 | GO:0000050 | urea cycle(GO:0000050) |
0.1 | 0.2 | GO:0070265 | necrotic cell death(GO:0070265) |
0.1 | 0.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.1 | 0.1 | GO:0050701 | interleukin-1 secretion(GO:0050701) |
0.1 | 0.2 | GO:0097049 | motor neuron apoptotic process(GO:0097049) regulation of motor neuron apoptotic process(GO:2000671) |
0.1 | 0.3 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.1 | 0.3 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.5 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.5 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.1 | 0.5 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.1 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.1 | 0.3 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 0.2 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.6 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.1 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.5 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.1 | 0.5 | GO:0007143 | female meiotic division(GO:0007143) |
0.1 | 0.1 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.4 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 0.3 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 2.7 | GO:0007127 | meiosis I(GO:0007127) |
0.1 | 2.4 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.1 | 0.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.1 | 0.9 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.1 | GO:0015810 | aspartate transport(GO:0015810) |
0.1 | 0.3 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.1 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 5.2 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.1 | 0.2 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.1 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.1 | 0.2 | GO:0044788 | modulation by host of viral process(GO:0044788) |
0.1 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.2 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.6 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.5 | GO:0051383 | kinetochore organization(GO:0051383) |
0.1 | 0.6 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.2 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.2 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.1 | 0.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.4 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.2 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.2 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.1 | 0.2 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.5 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.1 | 0.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.1 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 0.1 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.1 | 0.1 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.1 | 0.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.8 | GO:0048771 | tissue remodeling(GO:0048771) |
0.1 | 1.3 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 1.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.1 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.1 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.1 | 0.3 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.1 | 0.1 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.1 | 0.1 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.1 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.1 | 5.3 | GO:0051607 | defense response to virus(GO:0051607) |
0.1 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.5 | GO:0021591 | ventricular system development(GO:0021591) |
0.1 | 0.9 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 3.7 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.1 | 1.0 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.3 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.7 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.2 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.1 | 0.3 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.1 | 0.7 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.2 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.1 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
0.1 | 0.1 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
0.1 | 0.1 | GO:0050932 | regulation of pigment cell differentiation(GO:0050932) |
0.1 | 0.3 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.1 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.1 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.1 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.1 | 0.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.1 | GO:0061511 | centriole elongation(GO:0061511) |
0.1 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.3 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 0.2 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 0.6 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.1 | 0.1 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
0.1 | 0.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.1 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.2 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.2 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.1 | 1.2 | GO:0022404 | hair follicle development(GO:0001942) molting cycle process(GO:0022404) hair cycle process(GO:0022405) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.1 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.1 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.1 | 0.1 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.1 | 0.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.4 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.1 | GO:0009415 | response to water(GO:0009415) |
0.1 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.1 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 0.1 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.1 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.2 | GO:0071711 | basement membrane organization(GO:0071711) |
0.1 | 0.1 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.3 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.1 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.1 | 0.1 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.1 | 0.1 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.0 | 0.0 | GO:0048880 | sensory system development(GO:0048880) |
0.0 | 0.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.0 | GO:0097709 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) connective tissue replacement(GO:0097709) |
0.0 | 0.1 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.0 | 0.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 5.0 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0042119 | neutrophil activation(GO:0042119) |
0.0 | 0.3 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.0 | 0.8 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.0 | 0.0 | GO:0042348 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.0 | 1.3 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.0 | 0.0 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.0 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.0 | 0.1 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.0 | 0.3 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.2 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.0 | 0.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.0 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.0 | 0.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.0 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.0 | 0.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.2 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.1 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.0 | 0.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.2 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.0 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.0 | 0.0 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.1 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.0 | 0.0 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.0 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.2 | GO:0045190 | somatic recombination of immunoglobulin genes involved in immune response(GO:0002204) somatic diversification of immunoglobulins involved in immune response(GO:0002208) isotype switching(GO:0045190) |
0.0 | 0.0 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.0 | 0.0 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.0 | 0.0 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) |
0.0 | 0.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.1 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.0 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.0 | 0.0 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.0 | 0.0 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.0 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.7 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.0 | 0.0 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.5 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.0 | 0.0 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.0 | 0.1 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.0 | 0.0 | GO:0021564 | vagus nerve development(GO:0021564) |
0.0 | 1.6 | GO:0006310 | DNA recombination(GO:0006310) |
0.0 | 0.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.0 | GO:0044860 | protein transport into membrane raft(GO:0032596) protein localization to plasma membrane raft(GO:0044860) |
0.0 | 0.2 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.0 | GO:0071838 | cell proliferation in bone marrow(GO:0071838) |
0.0 | 0.0 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.0 | 0.0 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.0 | 0.0 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.0 | 2.6 | GO:0032496 | response to lipopolysaccharide(GO:0032496) |
0.0 | 0.2 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.3 | GO:1905037 | autophagosome organization(GO:1905037) |
0.0 | 0.0 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.2 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.0 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 0.0 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.3 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 32.1 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.1 | GO:0021783 | preganglionic parasympathetic fiber development(GO:0021783) |
0.0 | 0.0 | GO:0042634 | regulation of hair cycle(GO:0042634) |
0.0 | 0.0 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.0 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.0 | 0.0 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.0 | 0.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0014841 | skeletal muscle satellite cell proliferation(GO:0014841) |
0.0 | 0.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.0 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.0 | 0.1 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.0 | 0.2 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.1 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.0 | 0.1 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.0 | 0.0 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.0 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.0 | 0.1 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.0 | 0.1 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.0 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.0 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.1 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.0 | 0.0 | GO:0006266 | DNA ligation(GO:0006266) |
0.0 | 0.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.0 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.0 | 0.0 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.0 | 0.0 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.0 | GO:2000514 | regulation of CD4-positive, alpha-beta T cell activation(GO:2000514) |
0.0 | 0.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.0 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.0 | 0.0 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.0 | GO:0070741 | response to interleukin-6(GO:0070741) |
0.0 | 0.5 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.1 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.1 | GO:0097421 | liver regeneration(GO:0097421) |
0.0 | 0.0 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.2 | GO:0048144 | fibroblast proliferation(GO:0048144) |
0.0 | 0.0 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.0 | 0.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.0 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.0 | 0.0 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.1 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.0 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.0 | 0.1 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.0 | 0.0 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.0 | 0.0 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.0 | GO:2001179 | interleukin-10 secretion(GO:0072608) regulation of interleukin-10 secretion(GO:2001179) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.0 | 0.0 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.0 | 0.0 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
0.0 | 0.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.0 | GO:0048846 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.0 | 0.1 | GO:0042633 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
0.0 | 0.1 | GO:0070229 | negative regulation of lymphocyte apoptotic process(GO:0070229) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 19.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
3.8 | 23.0 | GO:1990462 | omegasome(GO:1990462) |
3.6 | 10.9 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
2.3 | 9.2 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
2.3 | 11.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
2.2 | 22.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
2.1 | 8.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
2.0 | 13.8 | GO:0032009 | early phagosome(GO:0032009) |
1.9 | 9.4 | GO:0030056 | hemidesmosome(GO:0030056) |
1.8 | 14.0 | GO:0031209 | SCAR complex(GO:0031209) |
1.6 | 8.0 | GO:0031094 | platelet dense tubular network(GO:0031094) |
1.6 | 4.7 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.5 | 14.9 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.5 | 44.4 | GO:0008305 | integrin complex(GO:0008305) |
1.5 | 13.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.4 | 8.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.3 | 6.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.3 | 3.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.3 | 5.0 | GO:0042583 | chromaffin granule(GO:0042583) |
1.3 | 3.8 | GO:0043293 | apoptosome(GO:0043293) |
1.2 | 36.1 | GO:0001772 | immunological synapse(GO:0001772) |
1.2 | 10.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
1.2 | 3.6 | GO:0005911 | cell-cell junction(GO:0005911) |
1.2 | 4.8 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.2 | 3.5 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.2 | 4.7 | GO:0042825 | TAP complex(GO:0042825) |
1.2 | 8.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.2 | 2.3 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
1.1 | 4.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.1 | 9.2 | GO:0051286 | cell tip(GO:0051286) |
1.1 | 4.5 | GO:1990130 | Iml1 complex(GO:1990130) |
1.1 | 3.3 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.1 | 7.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
1.1 | 5.4 | GO:0030870 | Mre11 complex(GO:0030870) |
1.1 | 33.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.1 | 7.4 | GO:0042382 | paraspeckles(GO:0042382) |
1.0 | 8.3 | GO:0043203 | axon hillock(GO:0043203) |
1.0 | 2.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
1.0 | 1.0 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
1.0 | 2.0 | GO:0001739 | sex chromatin(GO:0001739) |
1.0 | 8.0 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
1.0 | 11.9 | GO:0001891 | phagocytic cup(GO:0001891) |
1.0 | 5.8 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.9 | 6.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.9 | 2.8 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.9 | 4.7 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.9 | 20.5 | GO:0090544 | BAF-type complex(GO:0090544) |
0.9 | 2.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.9 | 7.4 | GO:0001650 | fibrillar center(GO:0001650) |
0.9 | 2.7 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.9 | 9.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.9 | 7.3 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.9 | 1.8 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.9 | 3.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.9 | 2.6 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.9 | 7.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.9 | 3.5 | GO:0000938 | GARP complex(GO:0000938) |
0.9 | 7.8 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.9 | 3.4 | GO:0032021 | NELF complex(GO:0032021) |
0.8 | 14.4 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.8 | 5.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.8 | 39.0 | GO:0005776 | autophagosome(GO:0005776) |
0.8 | 3.4 | GO:0033269 | internode region of axon(GO:0033269) |
0.8 | 3.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.8 | 3.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.8 | 2.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.8 | 2.5 | GO:0005712 | chiasma(GO:0005712) |
0.8 | 3.3 | GO:0072487 | MSL complex(GO:0072487) |
0.8 | 15.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.8 | 5.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.8 | 2.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.8 | 8.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.8 | 6.4 | GO:0005861 | troponin complex(GO:0005861) |
0.8 | 23.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.8 | 4.0 | GO:0005638 | lamin filament(GO:0005638) |
0.8 | 3.1 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.8 | 7.8 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.8 | 5.4 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.8 | 0.8 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.7 | 2.2 | GO:0097342 | ripoptosome(GO:0097342) |
0.7 | 3.0 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.7 | 2.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.7 | 0.7 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.7 | 2.2 | GO:0071203 | WASH complex(GO:0071203) |
0.7 | 2.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.7 | 2.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.7 | 4.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.7 | 7.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.7 | 2.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.7 | 4.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.7 | 13.9 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.7 | 22.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.7 | 2.0 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.7 | 7.5 | GO:0010369 | chromocenter(GO:0010369) |
0.7 | 5.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.7 | 6.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.7 | 2.7 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.7 | 2.7 | GO:0000322 | storage vacuole(GO:0000322) |
0.7 | 9.3 | GO:0031252 | cell leading edge(GO:0031252) |
0.7 | 0.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.7 | 1.3 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.7 | 2.0 | GO:0036156 | inner dynein arm(GO:0036156) |
0.7 | 2.6 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.7 | 35.8 | GO:0016605 | PML body(GO:0016605) |
0.6 | 0.6 | GO:0042585 | germinal vesicle(GO:0042585) |
0.6 | 0.6 | GO:0031523 | Myb complex(GO:0031523) |
0.6 | 1.9 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.6 | 10.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.6 | 4.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.6 | 5.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.6 | 1.9 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.6 | 1.9 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.6 | 2.5 | GO:0045180 | basal cortex(GO:0045180) |
0.6 | 2.5 | GO:0035363 | histone locus body(GO:0035363) |
0.6 | 6.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.6 | 4.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.6 | 3.6 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.6 | 3.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.6 | 1.8 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.6 | 1.8 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.6 | 6.6 | GO:0016580 | Sin3 complex(GO:0016580) |
0.6 | 1.2 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.6 | 1.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.6 | 3.0 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.6 | 1.8 | GO:0032437 | cuticular plate(GO:0032437) |
0.6 | 41.8 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.6 | 6.5 | GO:0032039 | integrator complex(GO:0032039) |
0.6 | 5.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.6 | 2.3 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.6 | 2.9 | GO:0097255 | R2TP complex(GO:0097255) |
0.6 | 5.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.6 | 0.6 | GO:0044292 | dendrite terminus(GO:0044292) |
0.6 | 2.8 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.6 | 1.1 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.6 | 4.4 | GO:0043196 | varicosity(GO:0043196) |
0.5 | 29.2 | GO:0005811 | lipid particle(GO:0005811) |
0.5 | 7.9 | GO:0000145 | exocyst(GO:0000145) |
0.5 | 1.0 | GO:0030891 | VCB complex(GO:0030891) |
0.5 | 4.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.5 | 0.5 | GO:0044440 | endosomal part(GO:0044440) |
0.5 | 11.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.5 | 1.6 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.5 | 1.6 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.5 | 2.6 | GO:0034399 | nuclear periphery(GO:0034399) |
0.5 | 4.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.5 | 1.6 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.5 | 1.5 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.5 | 19.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.5 | 3.6 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.5 | 2.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.5 | 2.0 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.5 | 2.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.5 | 1.5 | GO:0097441 | basilar dendrite(GO:0097441) |
0.5 | 1.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.5 | 1.4 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.5 | 1.9 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.5 | 1.4 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.5 | 2.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.5 | 1.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.5 | 1.9 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.5 | 4.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.5 | 2.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.5 | 2.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.5 | 26.2 | GO:0005795 | Golgi stack(GO:0005795) |
0.5 | 3.7 | GO:0070652 | HAUS complex(GO:0070652) |
0.5 | 1.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.5 | 17.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.4 | 1.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.4 | 1.8 | GO:0043198 | dendritic shaft(GO:0043198) |
0.4 | 0.4 | GO:0005652 | nuclear lamina(GO:0005652) |
0.4 | 0.4 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.4 | 1.7 | GO:0000125 | PCAF complex(GO:0000125) |
0.4 | 2.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.4 | 0.4 | GO:0045298 | tubulin complex(GO:0045298) |
0.4 | 0.9 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.4 | 1.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.4 | 43.3 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.4 | 3.8 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.4 | 22.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.4 | 9.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.4 | 3.8 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.4 | 0.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.4 | 4.6 | GO:0035102 | PRC1 complex(GO:0035102) |
0.4 | 5.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.4 | 2.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.4 | 0.8 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.4 | 3.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.4 | 2.0 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.4 | 1.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.4 | 1.2 | GO:0005771 | multivesicular body(GO:0005771) |
0.4 | 2.0 | GO:0097422 | tubular endosome(GO:0097422) |
0.4 | 1.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.4 | 1.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.4 | 7.9 | GO:0032040 | small-subunit processome(GO:0032040) |
0.4 | 2.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.4 | 3.9 | GO:0030914 | STAGA complex(GO:0030914) |
0.4 | 0.8 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.4 | 3.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.4 | 2.6 | GO:0042383 | sarcolemma(GO:0042383) |
0.4 | 1.1 | GO:0097413 | Lewy body(GO:0097413) |
0.4 | 7.5 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.4 | 0.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.4 | 1.1 | GO:0055087 | Ski complex(GO:0055087) |
0.4 | 7.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.4 | 8.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.4 | 1.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.4 | 1.8 | GO:0000796 | condensin complex(GO:0000796) |
0.4 | 5.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.4 | 1.1 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.4 | 18.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.4 | 2.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.4 | 0.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.4 | 29.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 1.7 | GO:0005579 | membrane attack complex(GO:0005579) |
0.3 | 25.1 | GO:0030496 | midbody(GO:0030496) |
0.3 | 1.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.3 | 2.0 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.3 | 1.0 | GO:0005642 | annulate lamellae(GO:0005642) |
0.3 | 0.7 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.3 | 4.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 1.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.3 | 1.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 20.4 | GO:0005938 | cell cortex(GO:0005938) |
0.3 | 2.0 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 1.0 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 1.3 | GO:0044299 | C-fiber(GO:0044299) |
0.3 | 0.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 0.6 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.3 | 3.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 2.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.3 | 1.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.3 | 0.9 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 3.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.3 | 1.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.3 | 3.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 1.8 | GO:0042581 | specific granule(GO:0042581) |
0.3 | 3.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.3 | 3.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 0.9 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.3 | 1.4 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.3 | 38.5 | GO:0000139 | Golgi membrane(GO:0000139) |
0.3 | 1.7 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.3 | 1.4 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.3 | 1.7 | GO:0031415 | NatA complex(GO:0031415) |
0.3 | 89.9 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.3 | 12.0 | GO:0005902 | microvillus(GO:0005902) |
0.3 | 18.0 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.3 | 0.8 | GO:0005745 | m-AAA complex(GO:0005745) |
0.3 | 0.5 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.3 | 2.7 | GO:0070469 | respiratory chain(GO:0070469) |
0.3 | 3.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.3 | 1.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.3 | 0.3 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 1.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.3 | 2.9 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.3 | 2.9 | GO:0002102 | podosome(GO:0002102) |
0.3 | 0.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 0.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 3.1 | GO:0097546 | ciliary base(GO:0097546) |
0.3 | 0.8 | GO:0071797 | LUBAC complex(GO:0071797) |
0.3 | 2.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 3.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.3 | 2.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 10.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.3 | 0.5 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.3 | 1.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 11.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 18.4 | GO:0005814 | centriole(GO:0005814) |
0.2 | 0.7 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.2 | 0.7 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 0.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.2 | 0.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 0.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 1.0 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 9.3 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 2.8 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.2 | 0.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 3.7 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 6.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 0.2 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.2 | 0.9 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.2 | 0.2 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.2 | 0.9 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 21.6 | GO:0016604 | nuclear body(GO:0016604) |
0.2 | 1.7 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 5.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 2.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 2.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 0.8 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 3.6 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 0.6 | GO:0045177 | apical part of cell(GO:0045177) |
0.2 | 1.3 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 8.2 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.2 | 1.2 | GO:0043194 | axon initial segment(GO:0043194) |
0.2 | 0.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.2 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 1.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 0.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 1.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 1.8 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.2 | 5.9 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.2 | 2.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 0.2 | GO:1990696 | USH2 complex(GO:1990696) |
0.2 | 0.6 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 0.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 0.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.2 | 0.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 0.4 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 4.5 | GO:0010008 | endosome membrane(GO:0010008) |
0.2 | 1.1 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 3.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 0.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 0.2 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 1.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 0.7 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 0.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 0.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 5.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 0.2 | GO:0042827 | platelet dense granule membrane(GO:0031088) platelet dense granule(GO:0042827) |
0.2 | 2.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.2 | 11.5 | GO:0005769 | early endosome(GO:0005769) |
0.2 | 0.7 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 5.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.2 | 0.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 3.8 | GO:0005903 | brush border(GO:0005903) |
0.2 | 0.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 2.0 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.2 | 1.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 0.5 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 0.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.2 | 2.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 2.3 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 3.1 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 0.3 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 1.1 | GO:0031430 | M band(GO:0031430) |
0.2 | 1.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 0.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 0.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.2 | 0.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 1.3 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.2 | 31.1 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
0.2 | 0.6 | GO:0030897 | HOPS complex(GO:0030897) |
0.2 | 0.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 1.3 | GO:0005874 | microtubule(GO:0005874) |
0.2 | 3.9 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 0.8 | GO:0002177 | manchette(GO:0002177) |
0.2 | 1.4 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.2 | 2.3 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.2 | 0.8 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 0.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 0.5 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 4.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 10.0 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 220.6 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 3.3 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.1 | 5.6 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) cytoplasmic side of membrane(GO:0098562) |
0.1 | 130.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 1.0 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 1.1 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.7 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 1.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 1.5 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 1.9 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 31.6 | GO:0009986 | cell surface(GO:0009986) |
0.1 | 4.2 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.1 | 0.7 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.4 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.3 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.3 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 1.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.7 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.1 | 12.1 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 1.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.5 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 0.8 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 2.3 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.3 | GO:0001939 | female pronucleus(GO:0001939) |
0.1 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 1.5 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 0.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 2.0 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 1.7 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 6.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.5 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 0.6 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.2 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.3 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 20.9 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.2 | GO:0001652 | granular component(GO:0001652) |
0.1 | 8.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 1.0 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.1 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.1 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.1 | 0.6 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 40.4 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 53.0 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 76.6 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 24.2 | GO:0031410 | cytoplasmic vesicle(GO:0031410) |
0.1 | 1.0 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 0.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.1 | GO:0036379 | myofilament(GO:0036379) |
0.1 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 1.4 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.1 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.1 | 3.6 | GO:0012505 | endomembrane system(GO:0012505) |
0.1 | 0.5 | GO:0033267 | axon part(GO:0033267) |
0.1 | 0.4 | GO:0030427 | growth cone(GO:0030426) site of polarized growth(GO:0030427) |
0.1 | 1.0 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 0.9 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.2 | GO:0044309 | neuron spine(GO:0044309) |
0.1 | 0.5 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.1 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.7 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 0.3 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.0 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.0 | 95.5 | GO:0005737 | cytoplasm(GO:0005737) |
0.0 | 3.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 1.0 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.0 | 0.5 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.0 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.0 | GO:0030684 | preribosome(GO:0030684) |
0.0 | 0.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.0 | 0.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.0 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.0 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.0 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 27.4 | GO:0016021 | integral component of membrane(GO:0016021) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 21.3 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
5.1 | 15.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
4.3 | 17.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
4.0 | 4.0 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
4.0 | 11.9 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
3.3 | 26.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
3.0 | 12.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
3.0 | 8.9 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
2.8 | 8.5 | GO:0035877 | death effector domain binding(GO:0035877) |
2.7 | 18.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
2.6 | 10.6 | GO:0051425 | PTB domain binding(GO:0051425) |
2.6 | 7.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
2.6 | 13.0 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
2.6 | 5.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
2.6 | 5.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
2.5 | 17.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
2.4 | 12.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
2.2 | 9.0 | GO:0015265 | urea channel activity(GO:0015265) |
2.2 | 8.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
2.2 | 6.6 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
2.2 | 8.7 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
2.2 | 6.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
2.1 | 19.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
2.0 | 6.1 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
2.0 | 10.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
2.0 | 5.9 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
2.0 | 5.9 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
2.0 | 9.8 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
1.9 | 7.7 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.9 | 1.9 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
1.9 | 5.6 | GO:0043199 | sulfate binding(GO:0043199) |
1.9 | 5.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.8 | 16.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
1.8 | 23.8 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
1.8 | 1.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.7 | 6.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.7 | 16.5 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
1.6 | 8.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.6 | 1.6 | GO:0004461 | lactose synthase activity(GO:0004461) |
1.6 | 4.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.6 | 4.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.6 | 7.9 | GO:0070513 | death domain binding(GO:0070513) |
1.6 | 7.9 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.6 | 4.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.5 | 6.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
1.5 | 7.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
1.5 | 7.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.5 | 6.1 | GO:0031014 | troponin T binding(GO:0031014) |
1.5 | 7.5 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
1.5 | 18.0 | GO:0051400 | BH domain binding(GO:0051400) |
1.5 | 3.0 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
1.5 | 5.9 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
1.5 | 4.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.5 | 4.4 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
1.4 | 10.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
1.4 | 5.7 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
1.4 | 5.7 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.4 | 4.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.4 | 4.2 | GO:0030911 | TPR domain binding(GO:0030911) |
1.4 | 4.2 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
1.4 | 4.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.4 | 1.4 | GO:0070538 | oleic acid binding(GO:0070538) |
1.4 | 5.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
1.3 | 6.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.3 | 5.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.3 | 5.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.3 | 7.6 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
1.3 | 2.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
1.3 | 1.3 | GO:0016436 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
1.3 | 10.0 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
1.2 | 5.0 | GO:0004370 | glycerol kinase activity(GO:0004370) |
1.2 | 4.9 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.2 | 2.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.2 | 4.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.2 | 4.8 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.2 | 18.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.2 | 5.9 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
1.2 | 4.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.2 | 1.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
1.2 | 10.6 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
1.2 | 1.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.1 | 8.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
1.1 | 5.7 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
1.1 | 4.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.1 | 6.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.1 | 21.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
1.1 | 3.3 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.1 | 4.4 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.1 | 1.1 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
1.1 | 3.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
1.1 | 6.5 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
1.1 | 6.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
1.1 | 1.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.1 | 6.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.1 | 3.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.1 | 2.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.1 | 2.1 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
1.1 | 7.4 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
1.1 | 4.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
1.0 | 4.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
1.0 | 4.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.0 | 3.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
1.0 | 3.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.0 | 3.1 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.0 | 8.2 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
1.0 | 8.1 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
1.0 | 5.0 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
1.0 | 9.0 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
1.0 | 4.9 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.0 | 3.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
1.0 | 2.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.0 | 8.8 | GO:0016004 | phospholipase activator activity(GO:0016004) |
1.0 | 5.9 | GO:0004064 | arylesterase activity(GO:0004064) |
1.0 | 6.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
1.0 | 12.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
1.0 | 2.9 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.9 | 2.8 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.9 | 4.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.9 | 3.7 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.9 | 27.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.9 | 18.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.9 | 15.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.9 | 9.0 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.9 | 4.5 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.9 | 31.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.9 | 5.3 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.9 | 1.8 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.9 | 1.8 | GO:0038132 | neuregulin binding(GO:0038132) |
0.9 | 9.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.9 | 2.6 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.9 | 11.3 | GO:0010181 | FMN binding(GO:0010181) |
0.9 | 5.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.9 | 2.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.9 | 4.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.9 | 1.7 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.9 | 6.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.9 | 3.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.8 | 5.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.8 | 6.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.8 | 3.4 | GO:0019209 | kinase activator activity(GO:0019209) |
0.8 | 8.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.8 | 6.7 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.8 | 2.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.8 | 22.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.8 | 3.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.8 | 5.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.8 | 2.4 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.8 | 6.4 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.8 | 13.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.8 | 4.0 | GO:0043559 | insulin binding(GO:0043559) |
0.8 | 2.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.8 | 12.6 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.8 | 4.7 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.8 | 3.9 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.8 | 8.5 | GO:0001846 | opsonin binding(GO:0001846) |
0.8 | 3.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.8 | 0.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.8 | 6.9 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.8 | 6.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.8 | 3.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.8 | 3.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.8 | 1.5 | GO:0015928 | fucosidase activity(GO:0015928) |
0.8 | 4.6 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.8 | 3.8 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.8 | 2.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.7 | 2.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.7 | 1.5 | GO:0045340 | mercury ion binding(GO:0045340) |
0.7 | 5.9 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.7 | 3.7 | GO:0008430 | selenium binding(GO:0008430) |
0.7 | 2.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.7 | 5.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.7 | 2.9 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.7 | 3.6 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.7 | 1.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.7 | 3.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.7 | 2.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.7 | 1.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.7 | 3.6 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.7 | 1.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.7 | 4.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.7 | 3.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.7 | 1.4 | GO:0038100 | nodal binding(GO:0038100) |
0.7 | 2.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.7 | 9.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.7 | 2.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.7 | 11.5 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.7 | 2.0 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.7 | 1.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.7 | 12.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.7 | 7.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.7 | 3.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.7 | 0.7 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.7 | 2.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.7 | 2.7 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.7 | 1.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.7 | 2.0 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.7 | 3.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.7 | 2.6 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.7 | 2.0 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.6 | 2.6 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.6 | 1.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.6 | 11.0 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.6 | 3.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.6 | 3.2 | GO:0046790 | virion binding(GO:0046790) |
0.6 | 51.0 | GO:0005178 | integrin binding(GO:0005178) |
0.6 | 4.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.6 | 1.9 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.6 | 2.5 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.6 | 1.9 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.6 | 2.5 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
0.6 | 1.9 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.6 | 4.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.6 | 17.7 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.6 | 1.8 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.6 | 3.0 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.6 | 7.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.6 | 4.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.6 | 3.6 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.6 | 2.4 | GO:0043723 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.6 | 1.8 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.6 | 1.2 | GO:0030984 | kininogen binding(GO:0030984) |
0.6 | 1.8 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.6 | 1.2 | GO:0019961 | interferon binding(GO:0019961) |
0.6 | 4.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.6 | 0.6 | GO:0051379 | epinephrine binding(GO:0051379) |
0.6 | 1.7 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.6 | 1.7 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.6 | 1.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.6 | 1.7 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.6 | 1.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.6 | 4.5 | GO:0034582 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.6 | 5.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.6 | 2.8 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.6 | 0.6 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.6 | 5.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.6 | 0.6 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.6 | 3.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.6 | 0.6 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.6 | 1.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.6 | 5.0 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.5 | 2.2 | GO:0015925 | galactosidase activity(GO:0015925) |
0.5 | 1.6 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.5 | 2.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.5 | 1.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.5 | 2.2 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.5 | 6.5 | GO:0005521 | lamin binding(GO:0005521) |
0.5 | 3.8 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.5 | 2.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.5 | 1.6 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.5 | 1.1 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.5 | 2.7 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.5 | 4.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.5 | 2.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.5 | 0.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.5 | 3.6 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.5 | 2.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.5 | 15.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.5 | 1.0 | GO:0031013 | troponin I binding(GO:0031013) |
0.5 | 3.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.5 | 1.0 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.5 | 4.6 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.5 | 12.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.5 | 1.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.5 | 5.1 | GO:0005522 | profilin binding(GO:0005522) |
0.5 | 2.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.5 | 3.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 1.5 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.5 | 2.5 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.5 | 48.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.5 | 4.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.5 | 1.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.5 | 1.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.5 | 1.5 | GO:0000339 | RNA cap binding(GO:0000339) |
0.5 | 6.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.5 | 2.5 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.5 | 9.4 | GO:0030506 | ankyrin binding(GO:0030506) |
0.5 | 1.5 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.5 | 1.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.5 | 4.8 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.5 | 1.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.5 | 6.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.5 | 4.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.5 | 0.9 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.5 | 1.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.5 | 0.5 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.5 | 2.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.5 | 1.9 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.5 | 5.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.5 | 0.9 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.5 | 7.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.5 | 2.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.5 | 1.4 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.5 | 31.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.5 | 9.1 | GO:0004407 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.5 | 3.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.5 | 5.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.5 | 3.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.5 | 0.9 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.5 | 1.8 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.5 | 2.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.4 | 4.5 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.4 | 1.8 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.4 | 4.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.4 | 10.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.4 | 0.9 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.4 | 4.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.4 | 5.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.4 | 7.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.4 | 0.9 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.4 | 2.6 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.4 | 4.4 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.4 | 1.7 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.4 | 75.4 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.4 | 2.2 | GO:0015288 | porin activity(GO:0015288) |
0.4 | 3.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.4 | 7.3 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.4 | 1.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.4 | 0.9 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.4 | 1.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.4 | 5.5 | GO:0008143 | poly(A) binding(GO:0008143) |
0.4 | 1.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.4 | 0.8 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.4 | 0.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.4 | 0.8 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.4 | 1.6 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.4 | 0.4 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.4 | 1.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.4 | 0.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.4 | 3.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.4 | 9.5 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.4 | 3.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.4 | 2.0 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.4 | 2.0 | GO:0017040 | ceramidase activity(GO:0017040) |
0.4 | 16.2 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.4 | 2.4 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 2.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.4 | 2.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 30.9 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.4 | 2.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.4 | 1.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.4 | 4.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.4 | 6.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 1.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.4 | 1.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.4 | 1.9 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.4 | 1.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 2.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.4 | 2.2 | GO:0005113 | patched binding(GO:0005113) |
0.4 | 2.2 | GO:0008494 | translation activator activity(GO:0008494) |
0.4 | 1.1 | GO:0070061 | fructose binding(GO:0070061) |
0.4 | 1.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.4 | 1.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.4 | 5.5 | GO:0019825 | oxygen binding(GO:0019825) |
0.4 | 3.6 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.4 | 4.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.4 | 0.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.4 | 3.3 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.4 | 0.7 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.4 | 9.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.4 | 1.4 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.4 | 3.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.4 | 1.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.4 | 0.4 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.4 | 2.5 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.4 | 1.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 1.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.4 | 0.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.4 | 0.4 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.4 | 0.4 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.4 | 1.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.4 | 2.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.3 | 3.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.3 | 1.4 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.3 | 1.7 | GO:0032183 | SUMO binding(GO:0032183) |
0.3 | 0.3 | GO:0019207 | kinase regulator activity(GO:0019207) |
0.3 | 0.3 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.3 | 9.9 | GO:0050661 | NADP binding(GO:0050661) |
0.3 | 0.7 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 2.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 0.7 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.3 | 0.7 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.3 | 1.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 1.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.3 | 2.0 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 1.0 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.3 | 1.0 | GO:0019808 | polyamine binding(GO:0019808) |
0.3 | 2.3 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.3 | 1.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.3 | 5.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 8.2 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.3 | 0.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.3 | 14.2 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.3 | 1.0 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.3 | 0.3 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.3 | 1.3 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.3 | 0.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.3 | 0.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.3 | 9.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.3 | 1.0 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.3 | 9.5 | GO:0015485 | cholesterol binding(GO:0015485) |
0.3 | 3.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 0.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.3 | 1.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 0.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 0.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 5.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 2.5 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.3 | 1.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 1.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 11.1 | GO:0005507 | copper ion binding(GO:0005507) |
0.3 | 8.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.3 | 0.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 18.7 | GO:0002020 | protease binding(GO:0002020) |
0.3 | 0.9 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.3 | 1.5 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.3 | 3.0 | GO:0004568 | chitinase activity(GO:0004568) |
0.3 | 5.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.3 | 0.6 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.3 | 2.1 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.3 | 2.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 5.7 | GO:0008483 | transaminase activity(GO:0008483) |
0.3 | 0.9 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.3 | 1.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.3 | 4.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 0.9 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 8.3 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.3 | 1.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.3 | 12.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.3 | 2.9 | GO:0015643 | toxic substance binding(GO:0015643) |
0.3 | 0.9 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.3 | 0.9 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.3 | 0.9 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.3 | 0.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.3 | 4.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 4.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.3 | 0.6 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.3 | 2.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.3 | 4.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.3 | 0.6 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.3 | 0.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 2.6 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.3 | 1.4 | GO:0048156 | tau protein binding(GO:0048156) |
0.3 | 11.6 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.3 | 2.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 76.4 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.3 | 2.3 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.3 | 0.8 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.3 | 3.3 | GO:0005542 | folic acid binding(GO:0005542) |
0.3 | 0.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 0.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.3 | 0.5 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 0.8 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.3 | 1.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.3 | 2.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 3.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 2.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.3 | 0.8 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.3 | 4.3 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.3 | 1.9 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.3 | 8.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.3 | 0.8 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.3 | 0.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.3 | 2.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.3 | 12.6 | GO:0008565 | protein transporter activity(GO:0008565) |
0.3 | 3.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 1.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 0.5 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 0.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.3 | 2.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.3 | 3.4 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.3 | 0.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 1.5 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.3 | 4.8 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.3 | 0.8 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.3 | 1.0 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.3 | 6.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.3 | 1.8 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 3.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 0.5 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 2.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 5.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 3.2 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
0.2 | 0.7 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 0.7 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.2 | 1.7 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 0.7 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 0.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 0.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 0.5 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 1.0 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 1.4 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.2 | 10.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 0.5 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.2 | 1.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 0.9 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 1.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 0.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.2 | 6.4 | GO:0010296 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) 3,4-dihydrocoumarin hydrolase activity(GO:0018733) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.2 | 0.2 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.2 | 0.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 0.7 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 1.6 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.2 | 1.4 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 1.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.2 | 1.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 0.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.7 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.2 | 2.5 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.2 | 0.2 | GO:0060229 | lipase activator activity(GO:0060229) |
0.2 | 0.7 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 0.5 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 0.9 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 0.9 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 0.7 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.2 | 4.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 1.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 0.2 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 0.4 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 1.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 4.4 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 0.4 | GO:0036033 | mediator complex binding(GO:0036033) |
0.2 | 2.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.2 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 1.3 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.2 | 0.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 0.6 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 0.9 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.2 | 0.4 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 0.8 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 0.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 1.3 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 1.5 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 0.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 0.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 1.0 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.2 | 7.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 4.3 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 5.1 | GO:0008907 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.2 | 1.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 0.8 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.2 | 2.4 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 6.4 | GO:0051117 | ATPase binding(GO:0051117) |
0.2 | 1.0 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.2 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 2.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 1.4 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 0.6 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 0.8 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.2 | 0.8 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 0.4 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 1.0 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 0.4 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 0.6 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 1.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 0.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 0.6 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.2 | 1.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 18.0 | GO:0018169 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.2 | 3.9 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 0.2 | GO:0015927 | trehalase activity(GO:0015927) |
0.2 | 0.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.4 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 1.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 0.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 1.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 0.5 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 1.4 | GO:0043176 | amine binding(GO:0043176) |
0.2 | 0.9 | GO:0034824 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.2 | 2.5 | GO:0016594 | glycine binding(GO:0016594) |
0.2 | 1.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.2 | 2.1 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 1.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 0.7 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 8.9 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.2 | 1.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 2.8 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.2 | 1.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.2 | 1.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 0.2 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.2 | 0.5 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 0.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.2 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 4.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 0.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 1.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 1.8 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 0.2 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.2 | 0.8 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 4.1 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.2 | 0.7 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 14.7 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.2 | 1.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 0.8 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 0.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 0.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.2 | 1.4 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 0.3 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.2 | 9.4 | GO:0051020 | GTPase binding(GO:0051020) |
0.2 | 0.2 | GO:1904680 | oligopeptide transmembrane transporter activity(GO:0035673) peptide transmembrane transporter activity(GO:1904680) |
0.2 | 0.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 2.5 | GO:0015926 | glucosidase activity(GO:0015926) |
0.2 | 1.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 0.5 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 0.6 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 1.5 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 5.0 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.2 | 0.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 1.1 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) succinate-CoA ligase activity(GO:0004774) |
0.1 | 0.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 1.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.6 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 2.5 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 1.9 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.4 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 24.6 | GO:0017171 | serine-type peptidase activity(GO:0008236) serine hydrolase activity(GO:0017171) |
0.1 | 0.4 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.1 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.1 | 6.0 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.1 | 0.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 2.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.7 | GO:0060589 | nucleoside-triphosphatase regulator activity(GO:0060589) |
0.1 | 0.4 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 1.2 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.1 | 0.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 1.1 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.4 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.6 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 1.4 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 0.8 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 4.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 1.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.4 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 3.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 0.2 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 9.3 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.8 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 0.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 2.7 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 0.2 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 0.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 2.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.5 | GO:0019842 | vitamin binding(GO:0019842) |
0.1 | 1.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 1.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 7.5 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 1.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 1.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.7 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 0.8 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.1 | 0.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.1 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.1 | 0.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 1.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.2 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 0.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 2.3 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 1.1 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.1 | 2.0 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 23.8 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 1.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.4 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 1.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 1.5 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 0.4 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 1.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.5 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 1.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.8 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 1.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 3.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 2.9 | GO:0005254 | chloride channel activity(GO:0005254) |
0.1 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 1.3 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.1 | 0.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.5 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 1.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.2 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 13.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.4 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 5.0 | GO:0005506 | iron ion binding(GO:0005506) |
0.1 | 1.4 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.2 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 1.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.5 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 1.1 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 1.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.1 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.9 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
0.1 | 0.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 3.0 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 2.4 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.4 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.1 | 9.0 | GO:0019901 | protein kinase binding(GO:0019901) |
0.1 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 2.2 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.5 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 5.3 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.3 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 6.2 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.1 | 0.3 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.1 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.1 | 0.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.1 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.1 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.1 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.5 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 0.2 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 0.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.1 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 1.2 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.2 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.0 | 0.3 | GO:0043178 | alcohol binding(GO:0043178) |
0.0 | 0.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.3 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.0 | 0.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 22.9 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.0 | 0.0 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.0 | 0.0 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.8 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.1 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.0 | 0.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.1 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.0 | GO:0048030 | disaccharide binding(GO:0048030) |
0.0 | 38.2 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:0016885 | CoA carboxylase activity(GO:0016421) ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.0 | 0.7 | GO:0060090 | binding, bridging(GO:0060090) |
0.0 | 0.0 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.0 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.3 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 1.1 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.2 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.0 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.1 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.5 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 2.6 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.2 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.0 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.0 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.0 | 0.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.0 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.0 | 0.0 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.0 | 0.3 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.0 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 0.2 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.0 | GO:0016895 | exodeoxyribonuclease activity(GO:0004529) exodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016895) |
0.0 | 0.1 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.0 | 0.0 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.0 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 0.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 31.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.6 | 22.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.4 | 34.0 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
1.3 | 33.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.3 | 15.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
1.2 | 35.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.2 | 16.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.1 | 47.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
1.1 | 6.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.0 | 24.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.0 | 4.0 | PID EPO PATHWAY | EPO signaling pathway |
1.0 | 6.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.0 | 42.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
1.0 | 1.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.9 | 19.0 | PID MYC PATHWAY | C-MYC pathway |
0.9 | 11.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.9 | 12.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.9 | 26.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.9 | 38.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.9 | 9.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.9 | 0.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.8 | 8.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.8 | 19.0 | PID AURORA A PATHWAY | Aurora A signaling |
0.8 | 4.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.8 | 20.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.8 | 3.9 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.8 | 2.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.8 | 18.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.8 | 20.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.7 | 31.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.7 | 15.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.7 | 6.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.7 | 24.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.7 | 2.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.7 | 11.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.7 | 4.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.6 | 8.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.6 | 13.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.6 | 16.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.6 | 26.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.6 | 10.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.6 | 26.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.5 | 5.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.5 | 6.9 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.5 | 1.6 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.5 | 2.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.5 | 2.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.5 | 5.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.5 | 1.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.5 | 9.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.5 | 7.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.5 | 14.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.4 | 20.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.4 | 17.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.4 | 0.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 5.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.4 | 8.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.4 | 13.5 | PID P73PATHWAY | p73 transcription factor network |
0.4 | 2.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.4 | 13.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.4 | 8.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.4 | 2.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 0.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.4 | 9.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.4 | 6.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.4 | 3.4 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.4 | 3.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.4 | 4.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 2.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 3.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 19.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.3 | 0.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.3 | 2.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 6.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.3 | 1.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 1.6 | PID ATM PATHWAY | ATM pathway |
0.3 | 0.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.3 | 2.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.3 | 3.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 2.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 10.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 5.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.3 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 2.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.3 | 2.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 6.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 3.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 4.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 1.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 4.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 0.7 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 0.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 1.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 1.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 25.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 0.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 6.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 0.5 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 2.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 1.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 1.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 1.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 0.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 1.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 0.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.2 | 0.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 1.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 2.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 3.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 0.7 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 1.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.7 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 20.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 2.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 2.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 2.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.4 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 3.3 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
3.2 | 25.8 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
3.1 | 30.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.9 | 22.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.8 | 24.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
1.7 | 20.6 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
1.6 | 34.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
1.6 | 16.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
1.6 | 30.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.5 | 10.5 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
1.4 | 14.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.4 | 2.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.3 | 9.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
1.3 | 1.3 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
1.3 | 13.3 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
1.3 | 13.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
1.3 | 17.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
1.2 | 13.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
1.2 | 14.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.1 | 15.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.1 | 7.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.1 | 11.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.1 | 4.4 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
1.1 | 17.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
1.0 | 8.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.0 | 1.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
1.0 | 26.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.0 | 10.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.0 | 23.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.9 | 9.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.9 | 20.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.9 | 4.5 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.9 | 18.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.9 | 11.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.9 | 14.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.9 | 1.8 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.9 | 13.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.8 | 7.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.8 | 19.7 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.8 | 17.9 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.8 | 7.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.8 | 10.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.8 | 11.8 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.8 | 7.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.7 | 13.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.7 | 12.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.7 | 16.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.7 | 22.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.7 | 8.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.7 | 4.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.7 | 16.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.7 | 15.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.7 | 8.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.7 | 6.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.7 | 3.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.6 | 5.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.6 | 2.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.6 | 5.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.6 | 12.8 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.6 | 18.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.6 | 11.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.6 | 5.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.6 | 5.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.6 | 1.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.6 | 8.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.6 | 11.9 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.6 | 4.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.6 | 8.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.6 | 1.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.5 | 11.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.5 | 8.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.5 | 3.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.5 | 4.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.5 | 4.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.5 | 1.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.5 | 5.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.5 | 27.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.5 | 7.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.5 | 4.0 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.5 | 5.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.5 | 26.7 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.5 | 13.8 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.5 | 5.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.5 | 0.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.5 | 31.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.5 | 13.0 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.5 | 3.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.5 | 6.0 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.5 | 10.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.5 | 0.9 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.5 | 1.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.4 | 10.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.4 | 6.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.4 | 1.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.4 | 5.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.4 | 1.7 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.4 | 11.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.4 | 2.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 4.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.4 | 37.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.4 | 1.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 4.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.4 | 3.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.4 | 11.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.4 | 2.7 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.4 | 5.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.4 | 1.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.4 | 0.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.4 | 1.9 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.4 | 10.4 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.4 | 12.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 4.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 8.6 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.4 | 6.8 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.4 | 0.4 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.4 | 3.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 1.0 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.3 | 19.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 6.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.3 | 8.0 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.3 | 2.7 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.3 | 3.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.3 | 3.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 6.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.3 | 4.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.3 | 1.9 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.3 | 7.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.3 | 0.3 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.3 | 0.6 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.3 | 2.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.3 | 3.3 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.3 | 2.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 1.2 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.3 | 2.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 4.9 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.3 | 1.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 2.0 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 10.7 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.3 | 4.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 1.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.3 | 1.1 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.3 | 0.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.3 | 1.8 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 2.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.3 | 41.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.3 | 0.8 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 3.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 2.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 11.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 1.0 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 1.4 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.2 | 10.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 2.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 3.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 2.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 2.2 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.2 | 6.0 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 0.9 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 2.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 1.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 1.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 2.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 2.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 1.7 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 1.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 4.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 0.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 1.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 1.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 6.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 1.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 1.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 0.8 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 3.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 3.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 1.9 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 2.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 2.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 0.5 | REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR | Genes involved in Downstream signaling of activated FGFR |
0.2 | 0.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.6 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 0.9 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.1 | 2.2 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.1 | 0.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 3.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 2.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 2.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.9 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 1.9 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 1.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 1.2 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.1 | 0.9 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 4.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 1.4 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 0.1 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 1.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 1.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 3.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 2.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.1 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.1 | 12.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.3 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.1 | 1.6 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.1 | 0.5 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 2.2 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 0.3 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 0.2 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.1 | 0.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 1.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 1.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.1 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 1.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 1.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 3.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 1.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.2 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.1 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |